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Abstract 
Pharmacological activation of presynaptic inhibitory group II mGluRs potently 
modulates excitatory synaptic transmission throughout the brain. However, little is 
known about the physiological conditions under which these receptors are activated by 
synaptically released glutamate. To routinely test for activation by action potential 
driven glutamate release, we applied a conditioning burst (7 stim at 100 Hz) to 
presynaptic axons in the presence (12.6 ± 1.3%, n=32; 100µM, 17 ± 2.4%, n=13) or 
absence (5.5 ± 0.9%, n=8) of the glutamate transporter blocker DL-TBOA (40uM) and 
assessed the resulting receptor activation with the mGluR antagonist LY341495 (3µM). 
The inhibition reached its maximum with 100µM DL-TBOA. However, strong 
glutamate transporter blockade did not only facilitate synaptic group II mGluR 
activation, it caused additionally a stimulation independent activation by accumulated, 
spontaneously released glutamate alone (19.9 ± 4.5%, n=5), which required the use of a 
lower DL-TBOA concentration (40µM) to keep mGluR activation facilitated but reduce 
spontaneous, stimulation independent mGluR effects to an insignificant degree (6.5 ± 
1.7%, n=5). Examining the mGluR mediated inhibition on the test fEPSP at different 
post burst intervals (PBI) revealed a peak depression at 0.2 ms PBI (13 ± 1%, n=34) 
which was still detectable even after 0.8 s PBI (8 ± 1%, n=7). The maximal inhibition of 
fEPSPs amounted to 30 ± 6% when applying 100 stim at 100 Hz using 0.2 sec PBI 
(n=9). Testing different frequencies within the conditioning burst revealed a maximum 
group II mGluR activation at 200Hz (23 ± 3%, n=10). To investigate the kinetics of 
group II mGluRs in more detail, we performed glutamate uncaging together with 
presynaptic Ca2+ imaging and assessed mGluR activation via uncaging-induced 
inhibition of presynaptic Ca2+ transients. We designed a laser stimulation protocol 
which yielded nearly rectangular steps in the extracellular glutamate concentration. 
Testing the activation time revealed a maximum depressed Ca2+ signal amplitude after 
450ms (16.7 ± 2.5%, n=3). An upper estimation for the deactivation showed an 
inhibition of Ca2+ entry upon glutamate uncaging slightly dropping to 65.6 ± 4.2% 
(n=5) 600 ms after uncaging and was still detectable after 2000 ms (16.5 ± 4.4%, n=3). 
When estimating the lower limit, the inhibition was gone after a 409 ms post-uncaging 
interval (1.7 ± 0.4%, n=6) (tau= 150ms). Summarizing fEPSP and imaging data, group 
Abstract 
14 
 
II mGluR activation kinetics was shown to be relatively fast (fEPSP rec.: tau= 40 ± 
20ms; Ca2+ imag.: tau= 150 ± 30ms), whereas the deactivation kinetics were indicated to 
be slower (fEPSP rec.: 840 ± 230ms; Ca2+ imag.: between 150 ± 110ms and 1870 ± 
60ms). These data support the idea that the functional significance of mGluRs as 
presynaptic autoreceptors is not the degree of inhibition, but rather a long duration of 
inhibition of glutamatergic transmission and that this function is due to intrinsically 
slow receptor kinetics. 
 
Keywords: presynaptic group II mGluRs, synaptic activation, presynaptic Ca2+    
imaging, glutamate uncaging, slow receptor kinetics 
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1 Introduction 
1.1 Glutamate 
Since the 1930’s when Krebs (1935) suggested that glutamate plays an important 
metabolic role in the brain, glutamate has been studied intensively. A few decades later 
it emerged that glutamate is the main excitatory neurotransmitter in the vertebrate brain 
(Fonnum, 1984) acting on three families of ionotropic receptors, named after their 
preferred agonists, N-methyl-D-aspartate (NMDA), 2a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) and kainate (Monaghan et al., 1989). Whereas AMPA 
and NMDA receptors incorporate ligand gated ion channels mainly permeable to Na+ 
and Ca2+, and less permeable to K+ (Asztely and Gustafsson, 1996), kainate receptors 
are predominantly permable to Na+ and K+ and only slightly to Ca2+ (Huettner, 2003). 
NMDA receptors can be distinguished from other types of ionotropic glutamate 
receptors because they show a voltage sensitive block induced by Mg2+ (Meldrum, 
2000). This is operative under normal circumstances but is overcome by partial 
depolarization of the resting membrane potential. Functionally, AMPA receptors are 
responsible for fast synaptic transmission, NMDA receptors mediate the slower 
component of the postsynaptic excitatory current, and kainate receptor activation rather 
seems to have a modulatory effect on synaptic communication (Mayer and Westbrook, 
1987, Forsythe and Westbrook, 1988, Boulton et al., 1992, Hollmann and Heinemann, 
1994, Castillo et al., 1997, Rodriguez-Moreno and Lerma, 1998, Meldrum, 2000, 
Huettner, 2003, Lerma, 2003).  
Before glutamate mediates synaptic transmission or gets involved in modulatory 
processes, it is synthesized in the cytoplasm and is stored in presynaptic vesicles for 
quantal release (Meldrum, 2000, Fremeau et al., 2001). The action potential triggered 
release of glutamate is Ca2+ dependent (Fonnum, 1984) and the removal of glutamate 
from the extracellular space after release is mediated predominantly by astrocytes 
(Bergles and Jahr, 1997) and diffusion (Min et al., 1998, Rusakov and Kullmann, 1998). 
Another finding that strengthened the dominant role of glutamate was the discovery of 
glutamate stimulating inositol phosphate formation in striatal neurons (Sladeczek et al., 
1985). Later on, it was shown that this process was mediated by a novel type of 
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glutamate receptor linked to inositol phospholipid metabolism (Sugiyama et al., 1987). 
The novel receptor was cloned and termed the metabotropic glutamate receptor 1 
(mGluR1) (Masu et al., 1991). This discovery dramatically altered the traditional view 
of glutamatergic neurotransmission because earlier it was believed that the action of 
glutamate was exclusively mediated by the activation of ionotropic receptors. The 
newly discovered neuromodulatory glutamate receptors provided a mechanism by 
which glutamate can modulate cell excitability and synaptic transmission via second 
messenger systems (Conn and Pin, 1997). It became evident, that glutamate activates a 
large family of glutamate receptors, mediating and modulating most of the excitatory 
neurotransmission in the mammalian central nervous system (CNS) (Ozawa et al., 
1998).  
 
1.2 Metabotropic glutamate receptors (mGluRs) 
1.2.1 History 
As mentioned in the previous section, metabotropic glutamate receptors were 
discovered in the mid 1980’s. A first hint was the finding that glutamate induced 
formation of inositol phosphate belonging to a major second messenger system 
(Sladeczek et al., 1985), indicating that glutamate does not act exclusively on ionotropic 
glutamate receptors. Additionally, a pharmacological study performed by Carl Cotman 
and colleagues (Cotman et al., 1986) demonstrated that L-2-amino-4-phosphonobutyrate 
(L-AP4) and L-serine-0-phosphate (L-SOP) reduced synaptic transmission without 
affecting the membrane potential or the input resistance of the recorded cell. Based on 
these findings they concluded that the site of action for the L-glutamate analogue L-AP4 
and its structural analogue L-SOP must be presynaptic. These antagonist had no effect 
on any of the excitatory amino acid receptors (AMPA-R, NMDA-R, Kainate-R) known 
so far. Thus, they were suggested to act on a fourth class of receptors but detailed 
descriptions were not made. Later studies provided evidence that under endogenous 
conditions, these modulatory effects are mediated by novel glutamate receptors (Masu 
et al., 1991), firstly described in 1987 (Sugiyama et al.). Later, the terminology 
“metabotropic glutamate receptor“ was created and further important steps were the 
1 Introduction 
17 
 
cloning of the first mGluR (Masu et al., 1991) and the description of the whole mGluR 
family in the early 1990s (Bockaert et al., 1993).  
Functionally, mGluRs are believed to modulate synaptic transmission (Pin and 
Duvoisin, 1995, Cartmell and Schoepp, 2000), but despite three decades of intensive 
research on mGluRs, little is known about the physiological action of these receptors 
and which endogenous mechanisms control their activation.  
1.2.2 Structure 
mGluRs belong to the class C G-protein coupled receptor (GPCR) super-family which 
also includes GABAB receptors, calcium sensing receptors, pheromone receptors and 
taste receptors (Pin et al., 2003). GPCRs in general are membrane bound proteins and 
activated by extracellular ligands. These receptors are composed of an N-terminal 
domain, 7-transmembrane-spanning domains and an intracellular C-terminal domain.  
“Metabotropic/glutamate/pheromone“-class C GPCRs differ from the other main 
families: “rhodopsin-like“-class A and “secretin-like“-class B GPCRs (Fredriksson et 
al., 2003, Chou, 2005). They possess a larger N-terminal domain that contains the 
endogenous ligand binding site. This part of the receptor is termed the Venus Flytrap 
Domain (VFD). Each VFD consists of two lobes sitting on top of each other with the 
ligand bound between them (Pin et al., 2004).  
A trait that distinguishes mGluRs from other class C GPCRs is the deviating coding 
sequence for the 7-transmembrane spanning domains. This part of the receptor is shown 
to be involved in G-protein coupling and coupling selectivity (Pin et al., 2003). The 
intracellular C-terminal end of the receptor mediates and modulates G protein coupling. 
Metabotropic glutamate receptors can form homo- as well as hetero-dimers (Romano et 
al., 1996, Doumazane et al., 2011). In the dimerized form, three conformational or 
activation states can be distinguished (Figure 1): the open-open (glutamate is not 
bound), open-closed (glutamate is bound to one VFD) and closed-closed (both VFDs 
are bound to glutamate) state (Niswender and Conn, 2010).  
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Figure 1. Schematic diagram of the mGluR dimer in different activity states. The two large 
extracellular domains of an mGluR dimer are called Venus Flytrap domains (VFDs). These 
domains bind glutamate and other orthosteric ligands. Seven transmembrane spanning domains 
are linked to the VFDs via cysteine-rich domains. The C-terminus faces intracellularly and is 
often subject to alternative splicing to generate different C-terminal protein tails. The open-open 
conformational state on the left side is the inactive state and can be stabilized by antagonists. A 
glutamate binding to either one or both VFDs results in a receptor activation. Picture is adapted 
from: Niswender and Conn, Annu. Rev, Pharmacol. Toxicol., Vol. 50, pp. 295 – 322, 2010 
 
1.2.3 Types, expression and functional relevance 
The ubiquitously expressed mGluR family composed of eight different subtypes is 
divided into three subgroups (group I-III) depending on sequence similarities, 
pharmacological profile and signal transduction mechanism (Nakanishi, 1994). mGluR 
type 1 and 5 belong to group I, type 2 and 3 constitute group II and the remaining types 
4, 6, 7 and 8 are allocated to group III. Whereas group I mGluRs are predominantly 
post-synaptically localized, group II and III mGluRs are dedicated to presynaptic sites 
(Figure 2) (Cartmell and Schoepp, 2000). Moreover, postsynaptic group I and 
presynaptic III mGluRs prevail in the terminal zone of synapses, facing towards the 
synaptic cleft and presynaptic group II mGluRs are mainly restricted to the pre-terminal 
site of the synapse, closer to the axonal part of the neuron and further away from the 
glutamate release site (Shigemoto et al., 1997).  
As mentioned in the previous section, mGluRs are coupled to G proteins. 
Characteristically, subtypes mGluR 1 and 5 (group I) are primarily coupled to Gq/G11 
proteins (Masu et al., 1991). In most cases, receptor activation stimulates phospholipase 
18 
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Cβ (PLCβ) and causes formation of inositol-1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG). Ins-1,4,5-P3 releases Ca2+ from intracellular stores and DAG 
activates protein kinase C. Via this second messenger cascade group I mGluRs 
positively trigger the excitability of the postsynaptic cell (Cartmell and Schoepp, 2000). 
Presynaptic group II mGluRs are coupled to Gi/Go proteins (Tanabe et al., 1993, Chavis 
et al., 1994, Kammermeier et al., 2003). Their activation inhibits cAMP formation and 
N or P/Q-type voltage sensitive Ca2+ channels, activates K+ channels and can also 
activate the MAPK and the phosphatidylinositol-3-OH-kinase [PtdIns(3)K]-mediated 
pathway (Pin and Duvoisin, 1995, Anwyl, 1999). These signalling pathways are 
negatively linked to synaptic transmission. Like group II mGluRs (type 2, 3), group III 
mGluRs (Type 4, 6, 7, 8) are also coupled to Gi/Go proteins and negatively regulate 
glutamate release from the presynapse (Pin and Duvoisin, 1995, Niswender and Conn, 
2010).  
In general it is believed that mGluRs inhibit synaptic transmission via the blockade of 
Ca2+ entry but recently, it was shown that the group III subtype mGluR8 acts without 
affecting Ca2+ influx (Erdmann et al., 2011). Rather, the inhibition could be explained 
by a decrease in the Ca2+ affinity of the release sensor and to a lesser extent by a 
reduction of the maximal release rate. The mGluR6 subtype differs from other group III 
mGluRs because the receptor is exclusively localized on the dendrites of ON bipolar 
cells of the retina. It responds to glutamate released from rod and cone receptor cells in 
the dark. There the activation of the mGlu6 receptor reduces excitability of ON bipolar 
cells by negatively regulating a membrane non-selective cation channel (Nakajima et 
al., 1993, Nomura et al., 1994, Vardi et al., 2000).  
It is important to mention that expression of mGluRs is not exclusively restricted to 
neurons. mGluR 5 (group I) and mGluR 3 (group II) can be expressed in glial astrocytes 
as well (Ohishi et al., 1993, Tanabe et al., 1993, Balazs et al., 1997, Aronica et al., 
2000).  
As already mentioned, mGluRs are broadly distributed throughout the CNS and are 
specifically localized at discrete synaptic and extra-synaptic sites in both neurons and 
glia. This variety implies that mGluRs must be involved in numerous functional 
processes in the brain. It is already known that, activation of mGluRs results in diverse 
actions on neuronal excitability and synaptic transmission due to modulation of ion 
channels and other regulatory signalling proteins (Niswender and Conn, 2010). 
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Moreover, the physiological role of an mGluR subtype is highly specific to the neuronal 
population and the sub-cellular location. For example postsynaptic group I mGluRs can 
induce hyperpolarization in midbrain dopamine neurons (Valenti et al., 2002), whereas 
elsewhere they can potentially act presynaptically to either decrease or increase 
transmitter release via the release of retrograde messengers like endocannabinoids 
(Maejima et al., 2001, Varma et al., 2001) and may even be located presynaptically 
(Schwartz and Alford, 2000).  
The widespread and heterogeneous distribution of mGluRs in the brain also makes them 
attractive drug targets because it was shown that mGluR function seems to be more or 
less critically involved in various neurologic and psychiatric disorders like epilepsy 
(Alexander and Godwin, 2006), anxiety (Swanson et al., 2005), schizophrenia 
(Moghaddam, 2004), depression (Pilc et al., 2008), pain syndromes (Bleakman et al., 
2006), Alzheimer’s disease (Lee et al., 2004) and Parkinson’s disease (Conn et al., 
2005). However, it has to be taken into account that most of these finding about 
potential functional roles of mGluRs are based on pharmacological rather than on 
physiological studies via testing the activation by the endogenous ligand glutamate.  
Indeed, there are a few in vitro studies dealing with synaptic activation of, for example, 
group II mGluRs via glutamate (Scanziani et al., 1997, Dube and Marshall, 2000, 
Awatramani and Slaughter, 2001, Kew et al., 2001) and in vivo studies that indicate an 
involvement of mGluRs in important neuronal processes (Grueter et al., 2008, Carzoli 
and Hyson, 2011). In the end it is important to perform a systematic analysis in order to 
find out how and when mGluRs activate under natural conditions and to shed light on 
the question of which physiological processes they might be involved in as modulatory 
triggers. 
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Figure 2. Localization of glutamate receptors at a theoretical CNS synapse. Group I 
mGluRs are predominantly localized postsynaptically facing towards the synaptic cleft. In 
contrast, group II and III mGluRs are located presynaptically, group II at the axonal, pre-
terminal site and group III terminally. Whereas all types of ionotropic glutamate receptors are 
situated in the active zone of the postsynapse, only mGluR 7 (group III) is located in the vesicle 
release area of the presynapse. Picture is adapted from: Cartmell and Schoepp, J. Neurochem., 
Vol. 75, No. 3, 2000 
 
 
1.2.4 Presynaptic group II mGluRs 
Many studies support the hypothesis that group II mGluRs function as a presynaptic 
regulatory mechanism to control neurotransmitter release (Pinheiro and Mulle, 2008) . 
Their predominant extra-synaptic location implies that they detect the extracellular 
build-up of glutamate, therefore acting as autoreceptors (Kew et al., 2001, Nicoll and 
Schmitz, 2005, Kwon and Castillo, 2008).  
Apart from that, it has been shown that presynaptic group II mGluRs can also act as      
hetero-receptors, controlling the release of GABA by inhibitory interneurons (Mitchell 
and Silver, 2000). Some other studies state for example, that most likely all group II 
mGluRs are activated by glutamate spillover and act exclusively hetero-synaptically 
(Scanziani et al., 1997, Pinheiro and Mulle, 2008).  
In the past decades, a multitude of studies tried to discover the potential roles 
presynaptic group II mGluRs might play in neuronal processes. Most of these studies 
were performed with selective pharmacological agents. One interesting finding is that 
group II mGluRs seem to be involved in different forms of short- and long-term 
plasticity (Pinheiro and Mulle, 2008). For example, at hippocampal mossy fibres/CA3 
pyramidal cell synapses they decrease frequency facilitation (Scanziani et al., 1997), 
whereas at thalamocortical synapses onto layer IV barrel cortex neurons (Mateo and 
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Porter, 2007), at the calyx of Held (von Gersdorff et al., 1997) and at the medial 
perforant path/granule cell synapse (Brown and Reymann, 1995) group II mGluRs 
contribute to the regulation of synaptic short-term depression. Moreover, compelling 
evidence has been provided that metabotropic glutamate receptors are essential for the 
induction of long-term potentiation (LTP) and long-term depression (LTD) in the 
hippocampus (Huang et al., 1997, Bortolotto et al., 1999). Further, in the case of group 
II mGluRs, it has been found that they are required for persistent LTD, but not for LTP 
in the hippocampal CA1 region (Altinbilek and Manahan-Vaughan, 2009). Generally, 
there are two forms of LTD group II mGluRs are required for: an electrically-induced 
LTD in the CA1 region that is protein synthesis-dependent (Manahan-Vaughan et al., 
2000) and a chemically-induced LTD in the dentate gyrus that is protein synthesis-
independent (Poschel and Manahan-Vaughan, 2005). Another study indicated that 
group II mGluRs could also be involved in mossy fibre LTD as evidenced by the lack of 
the mGlu 2 receptor in a knock-out mouse (Yokoi et al., 1996) but a re-examination of 
the group II mGluR role for mossy fibre LTD showed that group II mGluRs are neither 
necessary nor sufficient for the induction (Wostrack and Dietrich, 2009).  
As mentioned in the previous section, group II mGluRs seem to be also critically 
involved in a variety of neuronal disorders. For example, it is indicated that group II 
mGluRs might play a role in at least one form of epilepsy which is accompanied by a 
degeneration of the hippocampus because a pharmacological treatment with group II 
mGluR agonists revealed anticonvulsive effects (Dietrich et al., 2002). Additionally, 
mGluR2/3 agonists have been shown to decrease glutamate release in brain regions 
associated with fear and anxiety (Swanson et al., 2005). Adjacent to these effects, a 
group II mGluR mediated influence on neuronal excitability can in turn cause 
alterations in LTD or LTP (Anwyl, 1999) accompanied by changes in cognitive 
processes such as memory retention (Mathis and Ungerer, 1999) and spatial awareness 
(Altinbilek and Manahan-Vaughan, 2009). Indeed, group II mGluRs are not essential 
for the encoding of information, but they seem to be vital for the consolidation of 
memory (Riedel et al., 2003). Further, mGluR 2/3 receptors potentially play a role in the 
altered neurotransmission which might be part of the cause of schizophrenia. mGluR 2 
can form a complex with the serotonin 5-HT2a receptor, and it is suggested that a change 
in expression of both receptors could lead to altered signalling which may contribute to 
the manifestation of psychotic symptoms characterising schizophrenia (Gonzalez-
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Maeso et al., 2008). Neuronal circuits that might be altered through substance abuse 
also reflect a potential point of action for group II mGluRs (Olive, 2009) as well as 
physiological and behavioural processes influenced by depression (Chaki et al., 2004).  
Most of these findings on group II mGluRs and about mGluR types in general are based 
on pharmacological studies as mentioned in the previous section. This can be critical 
because too little is known about the physiological conditions under which these 
receptors might be activated and whether they really fulfil the potential (proposed?) 
functional role they are believed to have. So long as it is unknown whether endogenous 
group II mGluR activation corresponds to pharmacological activation, the possibility 
cannot be excluded that mGluRs do not act as autoreceptors. Eventually, the functional 
relevance of group II mGluRs must be reconsidered depending on future findings.  
 
1.3 Hippocampus as a model for the investigation of 
presynaptic group II mGluR recruitment and kinetics 
The hippocampus is one of the best investigated regions of the brain. The earliest 
description came from the Venetian anatomist Julius Caesar Aranzi (circa 1564). He 
was the first to coin the expression “hippocampus“, due to the enormous similarity to 
the tropical fish. After the advent of microscopy, it became possible to investigate the 
hippocampal anatomy on the cellular level. Camillo Golgi developed a new technique to 
illustrate the unique organization of this brain structure (1886) and Santiago Ramon y 
Cajal’s pioneering anatomical study on the stratification of the various afferent systems 
paved the way for later scientists to clarify the question of which functional role(s) the 
hippocampus plays in brain function (Andersen, 2007).  
Two reasons support the selection of the hippocampus for our study. First, the laminar 
arrangement of cellular pathways makes it a nearly perfect open-field structure 
(Johnston and Wu, 1995), allowing stimulation and recording from specific types of 
cells and second, the strong expression of group II mGluRs on medial perforant path 
fibres terminals (Shigemoto et al., 1997). 
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1.3.1 Anatomy 
The hippocampus is a paired structure located inside the medial temporal lobe and 
belongs functionally to the limbic system. The hippocampal region includes two sets of 
cortical structures, the hippocampal formation and the parahippocampal region. 
Important defining differences between the two are the number of cortical layers and the 
connectivity.  
Most commonly, the hippocampal formation is divided into three regions depending on 
the cytoarchitecture: dentate gyrus (DG), hippocampus proper (or Ammon’s horn) 
which is subdivided into three fields (CA3, CA2 and CA1), and subiculum. All three 
areas share the three layered structure and the unipolar connectivity (Witter, 1995). 
Here, the term hippocampus is used for the structure formed by the dentate gyrus and 
Ammon’s horn.  
The parahippocampal region includes the entorhinal, perirhinal and postrhinal cortices 
as well as the presubiculum and parasubiculum (Furtak et al., 2007). The latter two 
areas share the laminar organization, have more than three layers and are reciprocally 
connected with the subiculum (Scharfman et al., 2000). 
The three dimensional form of the rodent hippocampus is a relatively complex 
elongated structure with the long axis referred to as the septotemporal axis and the 
orthogonal axis as the transverse axis. The long axis is bent in a C-shape .  
The organisation of the major intrinsic hippocampal connections is described as a    
trisynaptic circuitry and characterized by the laminar arrangement of each group of 
these neurons (Figure 3) (Amaral and Witter, 1989). Strictly speaking, this is a 
simplified description of the main pathways involved in signal transmission and 
processing; however, it is sufficient to get an overview of the anatomical structure of the 
hippocampus. Originating in the entorhinal cortex, perforant path fibres project to the 
outer two-thirds of the dentate gyrus molecular layer, forming asymmetrical synapses 
with granule cell dendrites. The myelinated axons of the perforant path are on average 
0.1µm thin and show periodic varicosities with a thickness of 0.5 to 1.0µm (Amaral et 
al., 2007). Fibres that emanate from the lateral entorhinal area terminate in the most 
superficial third of the molecular layer, whereas fibres that originate from the medial 
entorhinal area terminate in the middle-third of the molecular layer. Elongated, un-
myelinated axons of granule cells, called mossy fibres, project to CA3 pyramidal 
neurons. These fibres give rise to unique complex presynaptic terminals called mossy 
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fibre expansions (or boutons). One feature that makes them unique is their size; they can 
be as large as 8µm in diameter, but typically they range from 3 to 5µm (Bischofberger 
et al., 2006). Axon collaterals given off by CA3 pyramidal neurons, called Schaffer 
collaterals, build connections with CA1 pyramidal neurons. A feature of these 
myelinated projections is that the axons vary in thickness. Lastly, the processed 
information propagates via the subiculum back to the entorhinal cortex (Amaral and 
Witter, 1989).  
 
 
 
Figure 3. Schematic view of the hippocampal anatomy and the synaptic connections of the 
main hippocampal pathway. Shown in the middle is a preparation in which the cortical 
surface overlying the hippocampus has been removed. The hippocampus is an elongated, C-
shaped structure with the long or septotemporal axis running from the septal nuclei rostrally (S) 
to the temporal cortex (T) ventrocaudally. The short or transverse axis (TRANS) is oriented 
perpendicular to the septotemporal axis. The slice pictured at top left is a representation of the 
major neuronal elements and intrinsic connections of the hippocampal formation. Schematized 
in the top right corner is a simplified diagram of the intrinsic circuitry of the hippocampal 
formation. Each of the fields is linked by unidirectional excitatory projections. Abbreviations: 
CA, Cornu Ammonis; DG, dentate gyrus; EC, entorhinal cortex; mf, mossy fibers; pp, perforant 
path; S, subiculum (upper circuitry schemes); S, septal nuclei (lower brain scheme); SC, 
Schaffer collaterals. Picture (modified) is adapted from: Amaral and Witter, Neuroscience Vol. 
31, No. 3, pp. 571-591, 1989 
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1.3.2 Function 
The hippocampus was believed to play an important role in certain forms of learning 
and memory. This assumption was intensified when case studies from patients who 
suffered from severe epilepsy showed a profound and selective loss of memory after 
surgical removal of the whole hippocampus (Scoville and Milner, 1957). H. M., the 
most famous of these patients, was impaired in a broad range of memory functions, 
including recognition of previously presented words or figures, free recall of noun pairs, 
and memory for the position of objects (Milner, 1965, Milner et al., 1968).  
Consistent evidence for hippocampal involvement in memory formation has also been 
obtained in tasks in which animals or humans used spatial memory for navigation 
(O'Keefe and Conway, 1978, Nadel, 1991). For example, it could be shown in rats that a 
significant portion of pyramidal cells have spatial firing correlates (O'Keefe and 
Dostrovsky, 1971, Muller, 1996). These so called “place cells“ show a spatially 
restricted firing pattern.  
The importance of the hippocampus for spatial mnemonic operations was also      
supported by findings showing that specific lesions of the hippocampal formation 
severely disrupted acquisition of spatial navigation tasks. Rats with such lesions, 
performing tasks in radial mazes failed to learn which arms were baited with food and 
which were not. They re-entered arms from which they had already collected food 
(Jarrard, 1978, Olton et al., 1978). 
It has been postulated that the brain uses short- and long-lasting modifications of 
synaptic strength in critical neuronal circuits to accomplish the processing and storage 
of information (Siegelbaum and Kandel, 1991, Malenka, 1994, Bear and Abraham, 
1996). Information that enters the hippocampus can underlie such changes caused by 
long-term plasticity effects as already described in section 1.2.4. Long lasting processes 
like LTD or LTP build on shorter-term processes to span the gap between synaptic 
plasticity and permanent structural changes involved in long-term memory (Zucker, 
1989) . 
 
1.3.3 Hippocampus and presynaptic group II mGluRs 
In the hippocampus of the rat, mGluRs are located fibre tract specific at the main 
synapses of the trisynaptic circuitry (Shigemoto et al., 1997). First evidences for group 
II mGlu receptor action at medial perforant path fibres in the dentate gyrus were 
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provided in 1996 (Macek et al.). At this location, group II mGluRs mediate inhibitory 
presynaptic modulation of synaptic transmission (Dietrich et al., 1997, Kew et al., 2001) 
and at mossy fibre synapses connecting CA3 pyramidal cells (Scanziani et al., 1997, 
Dietrich et al., 2003).  
In my project I focused on mGluR2/3 located at medial perforant path (MPP) extra-
synaptic sites because the expression level of group II mGluRs on this fibre tract is very 
high (Figure 4) (Shigemoto et al., 1997) and the laminar arrangement of the MPP fibre 
tract makes it best suited for electrophysiological recordings.  
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Figure 4. Distribution of immune-reactivity for mGluR2/3 in rat hippocampus. Shown on 
the upper part is a parasagittal section of the hippocampus reacted with a specific antibody for 
group II mGluRs. The immune-reactivity is restricted to the terminal zones of perforant path 
and mossy fibres. Marked by an arrow in the upper as well as in the lower part is the medial 
perforant path region where the expression level is most prominent. fi, fimbria; LM, stratum 
lacunosum moleculare; out, outer molecular layer; mid, middle molecular layer; in, inner 
molecular layer; Gr, granule cell layer. Picture (modified) is adapted from: Shigemoto et al., J. 
Neuroscience, Vol. 17, No. 17, pp. 7503-7522, 1997 
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1.4 Astrocytes 
Neuroglia were discovered in the late 1800’s (Montgomery, 1994) and Mihaly von 
Lenhossek was the first who used the expression ‘astrocyte‘ in 1895 to describe this 
specific class of glia cells. He intended to avoid the term glia that primarily implied a 
passive function for these cells. The name astrocyte is based on morphology because the 
round shape of the cell body and the outgrowing processes reminded Lenhossek (1895) 
of a cartoon of a star. However, the truth is that astrocytes are highly fibrous cells of 
great structural complexity and uniquely characterized by a dense array of processes 
(Nedergaard et al., 2003, Ransom et al., 2003).  
Together with oligodendrocytes, astrocytes constitute the major glial cell types within 
the central nervous system (CNS) (Jessen, 2004). They build a heterogeneous class of 
cells (Hansson, 1990, Zhang and Barres, 2010) with diverse functions similar to neurons 
(Sontheimer, 1992). Emsley and Macklis (2006) divided them into 9 classes based on 
immune-labelling methods (Matyash and Kettenmann, 2010).  
1.4.1 Morphology  
The morphology of astrocytes is determined by the cytoarchitecture of a given brain 
region. Depending on where astrocytes are located, the density can vary by a factor of 
1000 (Emsley and Macklis, 2006). Within one brain region several types of astrocytes 
can coexist (Matyash and Kettenmann, 2010). Common features of astrocytes are the 
expression of intermediate filaments which form the cytoskeleton. The main type of 
astroglial intermediate filament proteins is the glial fibrillary acid protein (GFAP) (Eng, 
1985). GFAP is commonly used as a specific marker to identify astrocytes (Raff et al., 
1979). Other characteristic features are a small soma diameter (~10µm), a low input 
resistance (≤ 30MΩ), a high resting potential (~ -95mV) and passive membrane 
properties (Diamond and Jahr, 2000).  
In contrast to other glia cells, astrocytes are characterized by the formation of end-feet 
that contact a basal lamina around blood vessels, the pia mater, or the vitreous body of 
the eye (Reichenbach, 2004).  
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Depending on the brain region, astrocyte processes surround pre- and postsynapses to a 
varying extent. In the hippocampus, 57% of the synapses are associated with the process 
of an astrocyte (Ventura and Harris, 1999). This form of neuron-glia assembly is termed 
the ‚tripartite synapse‘, a functional system where bidirectional information flow 
between astrocytes and neurons takes place (Araque et al., 1999). The role of astrocytes 
in this formation is to exchange information with the synaptic neuronal elements, to 
respond to synaptic activity, and in turn to regulate synaptic activity (Perea et al., 2009). 
It is important to mention that astrocyte processes do not fully insulate a synapse from 
the surrounding environment. They allow some flow into and out of the synaptic cleft. 
Some hippocampal synapses, for example, are astrocyte-free ranges. Potentially, 
substances could escape from these areas and activate receptors located extra-
synaptically or at neighbouring synapses (Ventura and Harris, 1999).  
Another feature of astrocytes is the expression of gap junctions mainly formed from the 
protein connexin 43. Gap junctions mediate intracellular communication by providing 
ultra-structural cytoplasmic continuity and allow astrocytes to form a functional 
syncytium (Bennett et al., 2003). 
 The astroglial types which have been described so far include: the main types called 
protoplasmic astrocytes (Eng, 1985) and fibrous astrocytes (Hildebrand et al., 1985) and 
the other types named tanycytes (Bruni et al., 1983), ’radial‘ cells (Kosaka and Hama, 
1986), Bergmann glia (Das, 1976), velate glia (Valverde and Lopez-Mascaraque, 1991), 
marginal glia (Braak, 1975), perivascular glia (Schnitzer, 1987), and ependymal glia 
(Reichenbach, 2004). In the molecular layer of the dentate gyrus, protoplasmic 
astrocytes predominate. The distribution of the cells is influenced by the boundary that 
separates the associational/commisural and the perforant path afferents (Bushong et al., 
2003).  
1.4.2 Transporter mediated glutamate uptake 
The main astrocyte functions range from guidance and support of neuronal migration 
during development, to modulation of immune-reactions, to maintenance of the 
neuronal microenvironment (Montgomery, 1994). Although astrocytes are assigned to 
different functional processes, their roles in these processes often overlap.  
One of the most important processes astrocytes are involved in is glutamate       
clearance after synaptic release. The uptake of glutamate from the extracellular space is 
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transporter mediated and electrogenic because the glutamate translocation is coupled to 
the electrochemical gradient for Na+, K+, and H+. During each transport cycle net 
positive charge is translocated across the membrane (three Na+ and one H+ into the cell 
and one K+ ion out of the cell for every molecule of glutamate by each transporter, 
(Figure5) which makes it possible to monitor glutamate transport electrophysiologically. 
 
     
Figure 5. Schematic illustration of glutamate uptake. The coupled transport of Na+ and K+ 
drives the uptake of glutamate and H+ down their concentration gradient. The cell membrane 
potential contributes to the uptake driving force due to a net inward movement of positive 
charge with each glutamate transported. Picture is adapted from: Anderson and Swanson, GLIA 
Vol. 32, pp. 1–14, 2000  
 
Astrocytes express the excitatory amino acid transporter (EAAT) termed GLAST 
(Glutamate aspartate transporter) (or EAAT1) and the glutamate transporter GLT-1 (or 
EAAT2) (Swanson et al., 1997, Anderson and Swanson, 2000). The high-affinity uptake 
of glutamate by GLAST and GLT-1 is the primary mechanism by which extracellular 
glutamate is maintained at low levels (< 1µM) (Meldrum, 2000). This is of great 
importance because the concentration of extracellular glutamate determines the extent 
of receptor activation. By limiting the extra-synaptic diffusion of glutamate, it is 
ensured that synaptic transmission occurs in a point-to-point fashion and that cross-talk 
between neighbouring excitatory synapses is minimized (Anderson and Swanson, 
2000). Apart from that, high levels of extracellular glutamate can cause excitotoxic 
effects (Danbolt, 2001).  
It is also important to mention that astrocytes-mediated glutamate uptake is highly 
temperature dependent (Asztely et al., 1997) and the transport process is accompanied 
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by pH changes, an alkalinisation of the outside and acidification of the inside of the cell 
(Bouvier et al., 1992, Amato et al., 1994).  
The degree to which the transporters shape the extracellular glutamate transient may 
also dependent on synapse geometry, transporter density and other varying factors 
among synapses (Bergles and Jahr, 1997).  
Clearance of extracellular glutamate by astrocyte glutamate transporters essentially 
limits the activity of metabotropic glutamate receptors at excitatory synapses (Huang et 
al., 2004), especially when the receptors are located extra-synaptically like group II 
metabotropic glutamate receptors.  
 
1.5 Aim of the study 
Pharmacological activation of presynaptic inhibitory group II mGluRs potently 
modulates synaptic transmission. However, little is known about the physiological 
conditions and the temporal and spatial pattern of glutamate release mediating group II 
mGluR receptor activation. Whereas ionotropic glutamate receptors can be activated by 
a single action potential, metabotropic glutamate receptors do not activate, even by a 
single vesicle (Manzoni et al., 1995, Dietrich et al., 1997, Scanziani et al., 1997). In a 
few studies, group II mGluR activation has been tested and it could be shown that 
repetitive stimulation is necessary to activate the receptors (Scanziani et al., 1997, Kew 
et al., 2001). Strikingly, the inhibition was drastically smaller compared to 
pharmacological activation. Despite this enormous discrepancy, nobody has performed 
a systematic analysis of group II mGluR activation.  
I sought to resolve this ambiguity and tested mGluR activation in detail by performing 
field potential recordings in the middle molecular layer of the dentate gyrus in 
horizontal hippocampal brain slices of Wistar-rats. My goals were to determine the 
presynaptic activity required for triggering group II mGluR activation, to find out how 
fast they activate and how long the activation lasts, and to determine which presynaptic 
factors substantially limit mGluR activation.  
In general, synaptic activation of presynaptic group II mGluRs is complex and 
influenced by many factors such as sub-cellular localization, the glutamate affinity and 
the glutamate accumulation in the ECS. To activate extra-synaptic group II mGluRs at 
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pre-terminals, a form of presynaptic activity is needed that causes strong extracellular 
glutamate dynamics after synaptic release, so that glutamate gets the chance to 
overcome the homeostasis between release and removal to diffuse and bind to the 
metabotropic glutamate receptor. The latter is predominantly controlled by astrocytes 
that perform fast electrogenic glutamate uptake after synaptic release (Takahashi et al., 
1997). This transporter mediated glutamate uptake plays a prominent role in mGluR 
activation because it limits glutamate concentration and diffusion distance in the ECS. It 
has been shown that, at physiological temperatures, synaptically released glutamate is 
rapidly removed from the extracellular space (Borg et al., 1976, Asztely et al., 1997), 
restricting the activation of pre-synaptically and pre-terminally located group II mGluRs 
(Huang and Bergles, 2004).  
The aim was to clarify how strongly mGluR activation is influenced by astrocyte 
glutamate uptake. In this study we tested, how strong mGluR activation is under 
physiological conditions and how the activation changes when the glutamate transporter 
blocker DL-TBOA is added in different concentrations to facilitate mGluR activation. 
In order to draw conclusions about the mGluR mechanism of action on synaptic    
transmission, it is important to resolve the kinetics of the inhibitory process. The shorter 
the time mGluRs need to activate fully, the shorter the required exposure to glutamate. 
Moreover, the characterisation of the deactivation kinetics would make clear whether 
the deactivation is determined by the glutamate level in the ECS or the intrinsic receptor 
and signal cascade kinetics. 
Finally, the systematic analysis of the inhibitory presynaptic group II mGluR activation 
and kinetics allowed more detailed assumptions to be drawn about the potential role of 
these modulatory receptors in neuronal processes and what it could imply for brain 
function. 
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2 Materials and Methods 
2.1 Animals 
2.1.1 Species 
Male Wistar rats between postnatal day 20 and 40 (nomenclature: Crl WI, Charles 
River, Sulzfeld, Germany) were used for field potential experiments as well as for   
combined Ca2+ imaging and glutamate uncaging experiments. Patch clamp recordings 
were performed on brain slices from rats between P20 and P30. 
2.1.2 Preparation of horizontal hippocampal slices  
Rats were anesthetized in a covered glass beaker using Isofluran (1-Chloro-2, 2, 2,-
trifluoroethyldifluoromethylether, Abbott GmbH & Co KG, Wiesbaden, Germany) and 
decapitated with a small rodent guillotine (DCAP, World Precision Instruments, 
Sarasota, FL, USA). The brain was transferred into ice cold ACSF (in mM): 87 NaCl; 
2.5 KCl; 1.25 NaH2PO;, 7 MgCl2; 0.5 CaCl2; 25 NaHCO3; 25 Glucose; 75 Sucrose (pH 
7.4) equilibrated with 95% O2/5% CO2 mixture. On a cooled, ACSF filled metal plate, 
the cerebellum was removed from the cerebrum and olfactory bulb (Figure 6A). The 
remaining two hemispheres were separated. A piece of the cortex was removed along 
the cranial-caudal axis (Figure 6B) and a piece of the basal forebrain was removed 
along the dorsal-ventral axis (Figure 6C). The prepared hemispheres were glued on a 
vibratome tissue holder, the cortex side being the glue site. 400µm (field potential 
recording) or 300µm (calcium imaging, patch clamp recording) horizontal hippocampal 
slices (Figure 6D) were prepared on a vibratome (Leica VT 1200S, Leica Microsystems 
GmbH, Wetzlar, Germany), transferred onto a net within a beaker filled with ACSF (in 
mM): 87 NaCl; 2.5 KCl; 1.25 NaH2PO;, 7 MgCl2; 0.5 CaCl2; 25 NaHCO3; 25 Glucose; 
75 Sucrose (pH 7.4), equilibrated with 95% O2/5% CO2 mixture and heated up to 35°C. 
After 30 minutes the slices were transferred to another beaker filled with ACSF (in 
mM): 124 NaCl; 3 KCl; 2 CaCl2; 2MgCl2; 1.25 NaH2PO4; 26 NaHCO3; 10 Glucose (pH 
7.4), equilibrated with 95% O2/5% CO2 mixture and kept at room temperature. All 
beakers were covered with parafilm (Pechiney Plastic Packaging, Chigago, IL, USA). 
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Figure 6. Sectioning-steps during hippocampal slicing procedure. (A) The cerebrum (Cer) is 
separated from cerebellum (Cereb) and olfactory bulb (OB) (B) a piece of the cortex along the 
cranial-caudal and (C) a part of the basal forebrain along the dorsal-ventral axis are removed 
(D) hippocampal slices are made along the cranial-caudal axis 
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2.2 Solutions 
2.2.1 Perfusion/ incubation solutions  
Artificial cerebrospinal fluid (ACSF)                                                                              
for room temperature (RT)    124 mM   NaCl 
           3 mM    KCl 
           1.25 mM   NaH2PO4   
           2 mM    MgCl2 
           2 mM    CaCl2 
           26 mM   NaHCO3 
           10 mM   Glucose   
Sucrose preparation solution                                                                                    
(“Messy-Ringer“)            87 mM   NaCl      
2.5 mM   KCl 
           1.25 mM   NaH2PO4 
           7 mM    MgCl2 
           0.5 mM   CaCl2 
           25 mM   NaHCO3 
           25 mM   Glucose   
           75 mM   Sucrose   
Artificial cerebrospinal fluid (ACSF)                                                                              
for physiological temperatures (35°C) 24 mM   NaCl 
           3 mM    KCl 
           1.25 mM   NaH2PO4 
           2 mM    MgCl2 
           2 mM    CaCl2 
           26 mM   NaHCO3 
           10 mM   Glucose   
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Artificial cerebrospinal fluid (ACSF)                                                                              
for physiological temperatures (35°C)                                                                                   
- “low calcium“       24 mM   NaCl 
           3 mM    KCl 
           1.25 mM   NaH2PO4 
           3 mM    MgCl2 
           1 mM    CaCl2 
           26 mM   NaHCO3 
           10 mM   Glucose  
 
2.2.2 Solutions for Patch clamp recordings 
Pipette solution       130 mM   K-gluconate 
           0.5 mM   MgCl2 
           4 mM    NaCl 
           5 mM    KCl 
           4 mM    Na2ATP 
           10 mM   HEPES 
           0.1%    Lucifer Yellow 
 
Sucrose preparation solution                                                                                          
with astrocyte marker                               87 mM    NaCl 
           2.5 mM   KCl 
           1.25 mM   NaH2PO4 
           7 mM    MgCl2 
           0.5 mM   CaCl2 
           25 mM   NaHCO3 
           25 mM   Glucose   
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           75 mM   Sucrose   
           1µM    Sulforhodamine 101 
2.2.3 Solutions for calcium imaging experiments 
Stock solution for dilution of calcium                                                                                      
AM dyes         250mg    Pluronic acid 
           1ml    DMSO 
 
 
Pipette solution with calcium AM dye                                                                                 
for positive pressure loading    30µl    25%  pluronic acid/ DMSO 
           200µl    ACSF (35°C) 
           50µg    Magnesium green AM  
 
 
Pipette solution with calcium AM dye                                                                                 
for positive pressure loading    30µl    25%  pluronic acid/ DMSO 
           200µl    ACSF (35°C) 
           50µg    Oregon green BAPTA 1 AM
             
                                                                                                                        
2.2.4 Solutions for histochemical analysis 
TRIS buffer (TBS) 0.1 M     12.12 g   TRIS 
           9 g     NaCl 
           1000 ml   Aqua dest        
pH adjustment with 1 M NaOH or 1 M HCl to 7.6 
 
 
Phosphate buffer saline (PBS) 10mM 150 mM   NaCl 
           1.9 mM   NaH2PO4 
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           8.1 mM   Na2HPO4       
pH adjustment with 1 M NaOH or 1 M HCl to 7.6 
 
PFA 8%         8 g     PFA 
           100 ml    1 mM PBS 
           12 drops   1 M NaOH  
           6 drops   1 M  HCl       
pH adjustment with 1 M NaOH or 1 M HCl to 7.4 
 
 
Staining protocol: GFAP gt anti-rb RRX 
 
Day 1    3 x 10 min wash with 0.1 M TBS 
     50µM thick slices of embedded (agarose) tissue 
     1 x 10 min wash-in 0.1 M TBS 
Day 1    3 slices per micro dish 
     Overnight 4°C:  485 µl    TBS 0.1 M 
           1 µl    anti-GFAP 
           10 µl    Triton X 10% 
 
Day 2    3 x 10 min wash with 0.1 M TBS 
     3 hours at 35°C:  485 µl    TBS 0.1 M 
           2.5 µl    gt anti-rb RRX 
           10 µl    Triton X 10%  
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2.3 Drugs and reagents 
 
 
Site of action Way of 
action 
Substance 
 
Vendor 
 
Solvent 
 
Final 
concentration 
Group II mGluRs Agonist DCG IV Tocris, Bristol, UK 
Water, 
ACSF 1µM 
Group II mGluRs Antagonist LY 341495 Tocris, Bristol, UK 
DMSO, 
NaOH 3µM 
mGluR 8 (group III) Agonist PPG Tocris, Bristol, UK NaOH 3µM 
mGluR 5 (group I) Antagonist MPEP Tocris, Bristol, UK 
Water, 
DMSO 10µM 
mGluR I (group I) Antagonist LY 367385 Tocris, Bristol, UK 
NaOH, 
Water 50µM 
GABAA-R Antagonist Bicuculline Tocris, Bristol, UK 
Ethanol, 
DMSO 10µM 
GABAB-R Antagonist CGP Tocris, Bristol, UK 
DMSO,  
Ethanol 2µM 
AMPA-R Antagonist CNQX Tocris, Bristol, UK Water 30µM 
AMPA-R Antagonist NBQX Tocris, Bristol, UK 
NaOH, 
DMSO 10µM 
NMDA-R Antagonist DL-AP5 Tocris, Bristol, UK 
Water, 
NaOH 
30µM, 50µM or 
100µM 
NMDA-R Antagonist MK 801 Tocris, Bristol, UK 
Water, 
DMSO 50µM 
GLAST, GLT-1 
 
Blocker 
 
DL-TBOA 
 
Tocris, Bristol, UK 
 
DMSO, 
Water 
10µM, 40µM or 
100µM 
Na+v channels 
 
Blocker 
 
TTX 
 
Alomone Labs,    
Jerusalem, Israel 
Water 
 
1µM 
 
Ca2+v channels Blocker Cobalt Sigma, St. Louis, MO Water 600µM 
Glutamate receptors 
 
Ligand 
 
γ-CNB-caged 
L-glutamic acid 
Invitrogen,          
Grand Island, NY 
ACSF 
 
250µM 
 
Table 1. List of drugs and reagents used in experiments. 
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2.4 Extracellular field potential recordings in the MML (DG) 
Field potentials are electrical signals measured between two points in the extracellular 
space and generated by electrical fields produced by the activity of a single neuron or a 
group of neurons. A field potential is composed of a presynaptic (fibre volley) and a 
postsynaptic component (population spike (pspike)).  
Depending on the geometric arrangement of neurons, three characteristic types of field 
potentials can be distinguished: the open field, the closed field and the open-closed 
field. The simplest form is the open field structure because the somas of laminarly 
organized neurons face in one direction and the dendrites in the other. The hippocampus 
is a typical representative for this arrangement (Johnston and Wu, 1995).  
In this study, field potential recordings were performed in the middle molecular layer 
(MML) of the rat hippocampal dentate gyrus (Figure 7). Medial perforant path fibres 
were stimulated and group II mGluR activation was assessed via the inhibition of the 
postsynaptic field potential component.  
 
REC STIM
 
Figure 7. Line drawing illustrating the main hippocampal synaptic connections and the 
area of stimulation and field potential recording. Both pipettes were positioned within the 
middle molecular layer to stimulate the medial perforant path projection incoming from the 
entorhinal cortex and to record the corresponding postsynaptic answer of the granule cells extra-
synaptically. Picture (modified) adopted from: The Rat Nervous System, 3rd Edition, 2004 by 
George T. Paxinos, Academic Press 
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2.4.1 Field potential recording setup 
The electrophysiological setup for field potential recordings (Figure 8) can be described 
as follows: horizontal hippocampal slices (thickness: 400µm) positioned on a piece of 
lens paper were laid on a net in an interface chamber, were perfused with 35°C warm 
ACSF equilibrated with 95% O2/5% CO2 mixture. Slice and electrode positioning, as 
well as the observation of the perfusion rate, were managed with the help of a 
stereomicroscope (Stemi 1000, Zeiss, Göttingen, Germany). A digital signal was 
transformed via an interface (ITC 16, Instrutech cooperation, Long Island, NY, USA) 
into an analog signal and sent to an isolated stimulator (custom made) to trigger 
stimulation. Signals detected by the recording pipette were pre-amplified (custom 
made), amplified (SEC-05 LX, npi, Tamm, Germany) and filtered at 3kHz. Data were 
sampled at 8kHz and stored on a computer for further analysis. 
 
Pre‐Amplifier
Amplifier
StimulatorITC 16
Oculars
Objective
Computer
Specimen
Stimulation pipette
Recording pipette
Interface chamber  
Figure 8. fEPSP recording setup.  
2.4.2 Electrodes 
1mm thick glass capillaries (GB150F-8P, Science products, Hofheim, Germany) were 
used to pull pipettes for stimulation and recording (pipette resistance: ~1-3MΩ). The 
glass capillary was fixed upright in a vertical puller (Model PP-830, Narishige, Japan) 
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and pulled in two steps. The heating temperature of the first pull-step mainly determined 
the angle of aperture and the heating temperature of the second pull step the diameter of 
the pipette tip. For extracellular stimulation and recording the pipettes were filled with 
ACSF (for physiological temperatures) and mounted on a cloridized silver wire fixed on 
a holder, so that the tip of the silver wire touched the ACSF.  
2.4.3 Positioning of electrodes 
The stimulation and recording electrode were positioned in the MML parallel to the 
medial perforant path fibre tract. Paired-pulse stimulation (stim: 0.1ms, 40ms IPI, ISI 
30s) was performed and fEPSPs were accepted for an experiment if they showed paired-
pulse depression to ~80% and if the amplitudes were stable between approximately 5 to 
20 minutes. The peak amplitude of fEPSPs usually exceeded 1mV. 
2.4.4 Stimulation protocol 
A flexible burst protocol programmed in Igor PRO (Wavemetrics Inc, Portland, OR, 
USA) was used to create different stimulation pattern, varying in burst length, number 
of given bursts, frequency, inter-burst interval (IBI) and post-burst interval (PBI). In 
general, the protocol was composed of a conditioning burst to activate group II mGluRs, 
and a test-stimulus to assess the mGluR effect on the field potential response. 
2.4.5 Experimental procedure 
Slices were transferred to the interface chamber and incubated for one hour before the 
measurement started. Stimulation and recording pipettes were positioned in the MML of 
the DG and the paired pulse plasticity was monitored for at least 20 minutes. After 
reaching a stable baseline, a conditioning burst was applied followed by a test-stimulus. 
Then the group II mGluR antagonist LY341495 was added and as soon as a steady-state 
of the blocking effect was reached the same stimulation protocol was applied again  
(approximately after ten minutes) (Figure 9). The mGluR activation was assessed by the 
antagonist (LY341495) mediated increase of the test-stimulus fEPSP and calculated by 
the following formula: 
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fEPSP peak test / fEPSP peak cond_1st 
fEPSP peak_LY test / fEPSP peak_LY cond_1st 
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facilitated mGluR activation
mGluRs antagonized with LY341495
1st
Conditioning burst Test-stimulus
 
Figure 9. Stimulation protocol 
 
2.4.6 Application of drugs 
Pharmacological substances were added to the bath solution (ACSF for 35°C) in a 
separate reservoir by perfusion (rate: 2ml/min). The solution was bubbled with 
carbogen. NMDA receptor blockers (DL-AP5 30-100µM and/or MK 801 50µM) were 
added in every field potential experiment to prevent LTP during high frequent repetitive 
stimulation.  
2.4.7 Analysis of fEPSP amplitudes 
Data were analyzed with custom macros in Igor PRO as well as in Excel and are 
presented as average ± standard error of the mean (SEM).  
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2.5 Presynaptic calcium imaging in the MML  
A procedure that can be used to study presynaptic calcium transients in rodent brain 
slices is monitoring presynaptic calcium dynamics with membrane permeable 
indicators. Rather than attempting to measure calcium levels in individual terminals, the 
strategy is to make an aggregate measurement from many presynaptic terminals. I 
utilized this method to investigate the temporal dynamics of group II mGluR mediated 
inhibition of synaptic transmission in detail. 
2.5.1 Electrophysiological and imaging setup  
The rat hippocampal brain slice (300µm) was positioned in a submerge chamber of an 
upright fluorescence microscope (Eclipse E600-FN, Nikon Instruments Inc., Melville, 
NY, USA) and held in place with a nylon harp fixed on a flattened platinum wire. The 
loading pipette and the stimulation electrode were mounted on a manipulator and driven 
by a stage control unit (SM. I, Luigs & Neumann, Ratingen, Germany).  
To stimulate the Ca2+ AM-ester-dye-loaded medial perforant path fibre tract 
(Magnesium Green AM or Oregon Green BAPTA-1 AM, Invitrogen, Molecular Probes, 
Darmstadt, Germany), a digital trigger signal was sent via the recording software TIDA 
(HEKA Elektronik Dr. Schulze GmbH, Lambrecht, Germany) to the interface (ITC16, 
Instrutech cooperation, Long Island, NY, USA) which converted the digital input into 
an analogue output and forwarded the signal to the isolated pulse stimulator (model 
2100, A-M SYSTEMS, Sequim, WA, USA). The stimulator sent a voltage pulse of 
defined duration (0.2-0.4ms) and strength (40-50V) to the stimulation electrode. 
Stimulation generated presynaptic action potentials in the MPP causing presynaptic 
Ca2+ influx. Within the terminals, Ca2+ binding to the fluorescent dye lead to a 
fluorescence emission increase. The fluorescent Ca2+ indicator was excited by light with 
470nm  wavelength (bandwidth ±30nm) (def.: light exhibits properties of waves and a 
wavelength is usually considered as distance between consecutive corresponding points 
of the same phase in such a sinusoidal wave. Light of specific colour matches a specific 
wavelength or a wavelength range) emitted from an LED light source (OptoLED, Cairn-
Research, Faversham, Kent, UK).  
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Fluorescent, band-pass filtered light (530 ± 43nm, AHF Analysetechnik AG, Tübingen, 
Germany) was detected by a light sensor (photodiode detector, Till Photonics GmbH, 
Gräfelfing, Germany) through a 60x objective (60x Fluor, DIC H, NA 1.00, WD 2.0, 
Nikon Instrutech cooperation, Long Island, NY, USA) and monitored with a CCD 
camera (model FK 7512 IQ, Pieper GmbH, Schwerte, Germany). A beam splitter unit 
mediated the dispersion of the corresponding light (model DCXRUV, AHF 
Analysetechnik AG, Tübingen, Germany). 
Fluorescent signals could be either amplified by increasing the gain of the voltage 
converter unit (Till Photonics GmbH, Gräfelfing, Germany) or by enhancing the gain of 
the amplifier (model EPMS 07, npi electronic GmbH, Tamm, Germany).  
The ITC 16 was supplied with the amplified voltage signal which in turn was 
transformed into a digital signal displayed on the oscilloscope and computer with the 
respective software (see the upper part of the section). 
If presynaptic Ca2+ imaging experiments were performed in combination with glutamate 
uncaging, a light fibre connected to a UV laser system (DPSL, Rapp OptoElectronic 
GmbH, Hamburg, Germany) was intercalated in the light path. A dicroic beam splitter 
within the optical system of the microscope was necessary to center the UV light with 
the excitation light on the specimen. In the lower graphic a schematic drawing of the 
imaging and recording setup is illustrated (Figure 10).  
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Pre‐AmplifierAmplifier
StimulatorITC 16
Detector
Oculars
Objective UV laser
Computer
Light source
CCD camera
Excitation filterEmission filter Dicroic beam splitter
Dicroic mirror
Specimen
Pressure port
Loading/ stimulation pipette
Submerge chamber  
Figure 10. Imaging and recording setup  
2.5.2 Loading of AM ester calcium indicator dye into the MPP fibre 
bundle 
To prepare the labelling solution, 50µg of the AM-ester indicator (here: Magnesium 
Green AM or OGB1 AM) was dissolved in 30µl solution of 25% pluronic acid 
(Pluronic F-127, Invitrogen, Molecular Probes, Darmstadt, Germany) and 75% dimethyl 
sulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO, USA) in a vial. The solution was 
vortexed for 30 seconds and sonificated for 3 minutes. Then 200µl artificial 
cerebrospinal fluid (ACSF for 35°C) was added and the solution was vortexed and 
sonificated again. The prepared mixture was filtered (Syringe Filter, 4mm, No. 
171/cellulose acetate membrane, Nalgene, Thermo Fisher Scientific, Rochester, NY, 
USA) and kept on ice.  
To load the indicator dye into rat brain slices the following protocol was used. The 
indicator dye solution was loaded into a pulled glass pipette via a spinal needle. Before 
the pipette entered the bath solution, slight positive pressure (0.5 units of a 1ml syringe, 
Becton Dickingson, Madrid, Spain) was applied to prevent it from blocking. Then, the 
loading pipette was lowered carefully near the surface of the slice. Step by step, the 
distance between the tissue and the pipette tip was minimized. The pipette was 
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positioned parallel within the medial perforant path fibre tract that was to be loaded. 
Additional positive pressure was applied, if the stream out of the pipette tip became 
weaker on the way to the slice surface. 
Next, the pipette was positioned in the ideal loading plane. If a slight movement of the 
tissue surrounding the tip could be observed, the condition was optimal, if not, more 
pressure was applied. After 20 to 40 minutes of loading, the pipette was removed and 
the bath heater (temperature controller V, Luigs & Neumann, Ratingen, Germany) was 
switched on to increase the temperature in the bath to 35°C in order to perform 
experiments at physiological conditions approximately 20 minutes subsequently. 
2.5.3 Electrodes 
For the loading, a 5 to 6MΩ pipette was used to keep the spot at the injection site small 
and the loading as specific as possible. For stimulation a 3 to 4MΩ pipette was used to 
elicit presynaptic action potentials in many axons of the medial perforant path fibre 
bundle (stimulus length 0.2-0.4ms, stimulus strength 40-50V). The tip of the loading 
pipette was filled with approximately 3 to 4µl labelling solution and the stimulation 
pipette contained the ACSF for physiological temperatures. 
2.5.4 Positioning of electrodes  
Loading or stimulation pipette were positioned approximately 10 to 15 µm deep within 
the Ca2+ indicator dye loaded medial perforant path fibre tract, depending on the 
optimally loaded plane. Generally the best suited region for electrode positioning was 
distal to the dye injection site which was mostly close to the site where the perforant 
path projections from the entorhinal cortex enter the dentate gyrus.  
2.5.5 Aperture 
The aperture defined the fluorescence detection area. The aperture stop was adjusted in 
size to get an approximately 20µm x 20µm wide imaging field. For Ca2+ imaging the 
aperture was positioned in front of the stimulation pipette (distance ~5µm), slightly un-
der the tip. For Ca2+ signal improvement, aperture and stimulation pipette position was 
carefully adjusted.  
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2.5.6 Analysis of MPP loading intensity and specificity 
The MPP loading quality was assessed by visual judgment and Ca2+ signal quality. 
 
2.6 Caged glutamate 
The caged amino acid neurotransmitter glutamic acid (L-glutamic acid, γ-(α-carboxy-2-
nitrobenzyl) ester, trifluoroacetic acid salt (γ-CNB-caged L-glutamic acid)) is biologi-
cally inactive before photolysis. Flash photolysis of the caging group with UV illumina-
tion at 355 nm results in a rapid and highly localized release of the free neurotransmitter 
at the site of illumination. γ-CNB-caged L-glutamic acid has the caging position at the 
carboxy end. This form of caged glutamate was chosen, because it combines rapid 
photolysis with high quantum efficiency. 
 
2.7 Uncaging light source 
γ-CNB-caged L-glutamic acid was dissolved in ACSF for physiological temperatures 
and added to the bath solution via perfusion. To obtain the best conditions for flash 
photolysis, the uncaging plane had to be adjusted to the imaging plane. Therefore, I 
performed tests with caged FITC (CMNB-caged fluorescein, Invitrogen, Eugene, 
Oregon, USA) while changing the coupling of the light fibre. CMNB-caged fluorescein 
is colourless and non-fluorescent before photolysis. Flash photolysis of the caging 
group with UV illumination at 355 nm results in fluorescein.  
For tests, a drop (~5µl) CMNB-caged fluorescein was put on a slide. After the drop was 
dry, a coverslip was fixed with nail polish on the slide to protect the substance from 
water. Then I proceeded as follows: a short UV laser pulse was applied to excite the 
caged fluorescein. The fluorescent spot was set in focus and defined as the optimal 
imaging place. Next, the coupling of the UV laser light fibre was changed 
systematically until the best uncaging plane matched the best imaging plane (Figure 
11A, right panel). This procedure was repeated with three light fibres of different 
diameter: 200µm (Figure 11), 400µm (not shown) and 1mm (not shown).  
In addition to this adjustment, the intensity of the UV light for each light fibre was 
tested in bleaching experiments (Figure 11B) and the effectiveness of glutamate 
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uncaging was assessed by the strength of group II mGluR activation induced decrease in 
Ca2+ signal size.  
 
A
B
 
Figure 11. UV laser flash photolysed CMNB-caged fluorescein – adjustment of imaging 
and uncaging plane. (A) The optimal imaging plane is at 0µm. In order to find the uncaging 
plane, the focus was set to different planes with reference to plane zero (down +, up -) and the 
uncaged spot was assessed after flash photolysis. Whereas the best uncaging plane did not 
match the optimal imaging plane on the right panel, it is well adjusted on the left. (B) UV laser 
pulses of different length were applied in order to evaluate the power of the laser while using a 
200µm thick light fibre. After 6ms of uncaging first bleaching effects were detectable, indicated 
by the black dot in the middle of the spot (scaling: 10µm). 
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2.8 Uncaging protocol design – Method 1: Voltage sensitive 
dye imaging with RH155 
To examine astrocyte transporter activity during flash photolysis of glutamate, I planned 
to optically monitor astrocyte membrane potential changes during transporter currents 
by using the voltage sensitive dye RH155 which labels astrocyte membranes and 
changes its absorption properties with membrane potential changes (Figure 12).  
For experiments, hippocampal slices (300µm) prepared from 20 to 40 day old Wistar 
rats were stained with the voltage sensitive dye RH155 (AnaSpec, San Jose, CA). This 
dye was reported to preferentially stain glial cells over neuronal cells (Konnerth et al., 
1987). Based on the publication from Chang and Jackson (2003) the concentration and 
incubation time for RH155 was adjusted to attain an optimal optical density value 
(absorbance) during absorption measurements which is 2 at best and calculated with the 
following formula: 
Aλ= - logn IRH155/ I 
We ended up with an incubation of 0.2mg RH155/ ml for 30min (Aλ ~2.2). The stained 
slice was placed in the submerged chamber, mounted on an upright fluorescent 
microscope, perfused with ACSF (for RT) and equilibrated with 95% O2/5% CO2 
mixture. The slice was illuminated with visible light of high power from the bottom 
side, dampened with neutral density filters (ND 1.3, 2, 4 corresponded to 5, 1 and 
0.01% transmission, AHF Analysetechnik AG, Tübingen, Germany) in order to keep 
the baseline signal around 6V. Additionally, a higher light intensity, together with a 
lower amplification factor (1x) improved the signal-to-noise ratio.  
The light that passed the tissue was filtered at 700nm (VersaCrome HC 700 ±13nm, 
AHF Analysetechnik AG, Tübingen, Germany). A photo-detector system (photodiode 
detector, Till Photonics GmbH, Gräfelfing, Germany) monitored the decrease in light 
intensity during RH155 absorption increase due to astrocyte membrane potential 
changes and converted the photocurrent into a voltage signal which was in turn 
transformed into a digital output (ITC 16, Instrutech cooperation, Long Island, NY, 
USA). Traces were filtered at 1kHz and sampled with 20kHz.  
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In all experiments, a 60x objective (60x Fluor, DIC H, NA 1.00, WD 2.0, Nikon 
Instrutech cooperation, Long Island, NY, USA) was used and the aperture 
(approximately 30 x 30µM) positioned above the middle molecular layer of the dentate 
gyrus. To check for RH155 signal, synaptic responses were evoked by delivering short 
pulses (stimulus length 0.3ms, IPI 5ms) to the medial perforant path fibre tract with a 3-
4MΩ glass electrode and optical signals were averaged over 10 trials.  
In the final experimental series, glial responses, as measured by dye absorption changes, 
were intended to be evoked by flash photolysis of caged glutamate. To prevent 
interference by UV light, it should be blocked by a long pass filter (Brightline HC 
409/LP, AHF Analysetechnik AG, Tübingen, Germany) which unfortunately did not 
work properly.  
At the end, tests revealed that this method was not suited for my purpose (section 3.3.1) 
and I had to take another approach in order to design an uncaging protocol.  
 
  
Figure 12. A schematic example of a voltage imaging system. The VSD stained slice is 
illuminated from the bottom. The light is filtered at 700nm, leading to an absorption increase of 
RH155 (see trace at the lower right corner), The picture is adapted from: Chang and Jackson, J. 
Membrane Biol., Vol. 196, pp. 105- 116, 2003 
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2.9 Uncaging protocol design – Method 2: Measuring 
astrocyte glutamate transporter currents 
As already mentioned, the electrogenic glutamate uptake of astrocytes follows the time 
course of extra-synaptic glutamate. To measure the transporter current directly I patch 
clamped astrocytes. In the following section the experimental setup and procedure is 
described in detail. 
2.9.1 Patch clamp setup and experimental procedure 
Horizontal hippocampal slices were prepared according to the technique described in 
section 2.1.2. Thereafter, the slices (300µm) were transferred into 35°C warm, sucrose-
ACSF for approximately 20-30 minutes and were subsequently incubated for 25 
minutes in sucrose ACSF containing 1µM Sulforhodamine 101 (Invitrogen, Molecular 
Probes, Darmstadt, Germany), a fluorescent dye that preferentially stained astroglial 
cells. The solution was allowed to come to room temperature.  
After staining, the slices were kept in RT-ACSF for at least 15 minutes before they were 
used for patch clamp recordings. For an experiment, slices were treated as described in 
the first part of section 2.5.1. The slice was perfused with 35°C-ACSF (rate: 1ml 
/minute) using a Minipuls 3 pump (Gilson, Middleton, WI) and bubbled with carbogen.  
By illuminating the slice with 590nm LED light (OptoLED, Cairn, Faversham, Kent, 
UK) the fluorescent astrocyte indicator sulforhodamine 101 was excited and the emitted 
light was detected by a CCD camera (model FK 7512 IQ, Pieper GmbH, Schwerte, 
Germany), so that astrocytes could be pre-selected under magnification (60x objective, 
Fluor DIC H, 1.00W, WD 2.0, Nikon, Melville, NY, USA) for patch clamp 
experiments. The patch pipette was filled with 130 mM K-gluconate, 0.5mM MgCl2, 4 
mM NaCl, 5 mM KCl, 4 mM Na2ATP, 10 mM HEPES and 0.1% Lucifer Yellow CH 
dipotassium salt (Sigma-Aldrich, St. Louis, MO, USA). The liquid junction potential of 
the gluconate based solution was -10mV with respect to the external solution.  
In the whole cell mode, the fluorescent dye Lucifer Yellow (excitation wavelength 
470nm) spread into the cell’s fine processes and facilitated the assessment of the 
morphology. Whole cell patch clamp recordings of astrocytes were performed using a 
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patch clamp amplifier (EPC 7, HEKA Elektronik Dr. Schulze GmbH, Lambrecht, 
Germany). All recordings were acquired with an ITC16 (Instrutech cooperation, Long 
Island, NY, USA) and operated by IgorPRO (Wavemetrics Inc, Portland, OR, USA) and 
TIDA (HEKA Elektronik Dr. Schulze GmbH, Lambrecht, Germany) for Windows. 
IgorPro was used to monitor whole cell mode stability (filter 5kHz) whereas TIDA was 
used to measure compensatory currents arising during electrogenic uptake of glutamate 
by astrocytes (20mV/pA, filter 1kHz) elicited via UV laser uncaging (Rapp 
OptoElectronic GmbH, Hamburg, Germany) of γ-CNB-caged L-glutamic acid. Data 
were sampled at 20kHz and stored on a computer for further analysis. A schematic 
drawing of the patch clamp system is shown in the following graphic (Figure 13). 
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Figure 13. Imaging and patch clamp setup.  
2.9.2 Astrocyte identification 
First, astrocytes were identified by means of morphological features. As the name 
suggests, astrocytes are process-bearing stellate or star shaped cells distributed 
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throughout the brain and spinal cord and possess small cell bodies (~10µm). They are 
divided into protoplasmic and fibrous types. 
The major identifying ultra-structural feature of astrocytes is the presence of 
intermediate filaments. These filaments are present in both types but much more 
prominent in fibrous astrocytes than in protoplasmic. In the dentate gyrus, protoplasmic 
astrocytes were predominantly found.  
Second, astrocytes could be identified immunhistochemically. The major component of 
glial fibrils is the glial fibrillary acidic protein (GFAP) which is relatively specific for 
astrocytes in the CNS. Therefore, if a cell was positively stained for GFAP (Dako, 
Glostrup, Denmark) after patch clamp, the probability was high that this cell was an 
astrocyte. Astrocytes in acute brain slices could be labelled with the fluorescent dye 
sulforhodamine 101 (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) to make a 
pre-selection for patch clamp experiments. Additionally, the patch clamp pipette was 
filled with the fluorescent dye Lucifer Yellow CH dipotassium salt (Sigma-Aldrich, St. 
Louis, MO, USA) to visualize the fine-architecture of the patched cell such as the 
intermediate filaments. 
Third, astrocytes could be identified electrophysiologically. The cells were 
characterized by passive membrane properties, a low input resistance (≤ 30MΩ) and 
strongly negative resting potential (approximately -80 to -90mV). 
2.9.3 Whole cell configuration 
Astrocyte transporter currents were measure in the whole cell configuration during 
pharmacological isolation (10µM NBQX, 100µM DL-AP5, 50µM MK801, 10µM 
MPEP, 1µM TTX, 50µM LY367385, 40µM DL-TBOA (if required)). Strictly speaking, 
it was not the transporter current that was measured but rather the current injected to 
compensate the membrane potential changes during glutamate transporter activity 
elicited by glutamate uncaging.  
Before a cell could be measured in the whole cell mode, the cell attached configuration 
had to be reached. This means the electrode (~4 to 5 MΩ) was sealed to the patch of 
membrane while the cell remained intact and capacitive currents occurring during the 
sealing process were compensated. To attain a whole cell configuration, the electrode 
was left in place on the cell and more suction was applied to rupture the membrane 
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patch, providing access to the intracellular space of the cell. Access resistance was 
monitored continuously during the experiment and was typically around 10MΩ.  
2.9.4 Voltage clamp mode 
In the voltage clamp configuration the cell was kept at a negative potential (-80mV), 
assumed to be the resting potential of the cell. This made it possible to measure ionic 
current crossing the cell's membrane at the given voltage during flash photolysis of 
glutamate and allowed a comparison between recorded astrocyte transporter currents. 
This technique is suited to analyze single currents but not really applicable to draw 
conclusions about the physiological excitation pattern of a cell.  
2.9.5 UV laser uncaging protocol design 
Whole-cell patch clamped astrocytes in voltage clamp configuration isolated from 
currents other than glutamate transporter currents were exposed to perfused γ-CNB-
caged L-glutamic acid (250µM) at 35°C. The uncaging spot (200µm light fibre 
diameter) was centered on the astrocyte’s soma and the astrocyte itself was in focus. UV 
laser flash pulses were applied in order to evoke a glutamate transporter current.  
The aim was to quickly (or directly) reach a current which was relatively strong (time 
constant τ ~11ms; ~30pA) at the beginning, remained constant in a tenth to hundredth 
millisecond range and declined quickly after uncaging (the time constant τ describes the 
time an exponential rising or decaying process need to reach 63.2%, respectively 36.8% 
of its initial value). To achieve this, UV illumination time and inter-pulse interval were 
adjusted.  
2.9.6 Application of drugs 
Pharmacological substances were dissolved in ACSF for 35°C , kept in an extra beaker 
and applied either by perfusion or by adding them directly to the solution in the 
submerge chamber (true for caged glutamate and the mGluR antagonist LY341495). 
After caged glutamate was added and perfused once, the solution was recycled for the 
rest of the experiment. The perfusion rate was 1ml per min. 
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2.9.7 Analysis of glutamate transporter transients 
Data acquired with the software TIDA (HEKA Elektronik Dr. Schulze GmbH, 
Lambrecht, Germany) were displayed and analyzed with IgorPRO (Wavemetrics Inc, 
Portland, OR, USA). 
 
2.10 Combinatory Ca2+ imaging and uncaging protocol 
For simultaneous Ca2+ imaging and glutamate uncaging the following stimulation 
protocol was designed (Figure 14, top). In the first part, a pre-stimulus pulse (P, 0.2-
0.4ms, 40-50V) was applied followed by a series of UV laser flashlights (e.g. 
1x50ms/ISI 6ms, 11x6ms/ISI 30ms, PUI 32ms) to uncage glutamate, and a test-stimulus 
(T, 0.2-0.4ms, 40-50V) was subsequently applied. During stimulation the corresponding 
Ca2+ transient was measured. In the second part, only a pre- and a test-stimulus were 
given. Next, the percentage inhibition of the presynaptic Ca2+ signal maximum 
mediated by uncaging evoked group II mGluR activation was calculated by using the 
following formula (L: UV laser, NL: no UV laser):    
 
                                                     ∆F/F test_L / ∆F/F pre_L 
∆F/F test_NL / ∆F/F pre_NL 
 
If Magnesium Green AM was used, the protocol was slightly changed. The protocol 
was repeated three times and an average value for each (response to pre- and test-
stimulus) maximum Ca2+ signal was calculated.  
In order to resolve the latency and activation kinetics of group II mGluRs, the duration 
of uncaged glutamate exposure time was varied, starting with one longer laser pulse. 
Then, the exposure to a constant uncaged glutamate concentration was prolonged step 
by step by adding further shorter stimuli to the laser protocol until the Ca2+ signal was 
maximally inhibited (Figure 14, middle). In a single experiment, only one data point per 
exposure time could be acquired.  
In the next step, the time interval between the end of uncaging and the test-stimulus was 
increased to determine the time the Ca2+ signal needed to recover to its initial size 
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(before mGluR activation) (Figure 14, bottom). To assess the deactivation kinetics 
reliably, sufficient group II mGluR activation during uncaging was required, but the 
activation did not have to be maximal. 
1st part 2nd part
Pre-stim Test-stim Pre-stim Test-stimUV stim
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Figure 14. Combined stimulation, uncaging and imaging protocol. The protocol consists of 
two parts: in the first part, the Ca2+ response to a pre-stimulus (Pre-stim) and a test-stimulus 
(Test-stim) following flash photolysis of glutamate (UV stim) was imaged. In the second part 
only a pre- and a test-stimulus were applied. The mGluR mediated inhibition was assessed by 
comparing the Ca2+ transient depression after uncaging with the Ca2+ transient change without 
uncaging. The number of protocol repetitions and the order of uncaging (in the first or second 
part) varied depending on the Ca2+ indicator used. To resolve the latency and activation kinetics, 
the duration of flash photolysis was prolonged until maximum inhibition was reached and the 
PUI was kept constant. In contrast, to determine the deactivation kinetics, the uncaging time 
was kept constant and the post uncaging interval (PUI) increased until the Ca2+ transient 
recovered back to initial size. 
 
2.11 GFAP Immunhistochemistry 
After successful astrocyte patch clamp experiments, the horizontal hippocampal slices 
(300µm) were transferred into a minidish (TC-Plate 24 well, Greiner Bio-One GmbH, 
Frickenhausen, Germany) and incubated in PFA (8%) for 24 hours. Afterwards, they 
were washed with TRIS buffer (TBS, 0.1 M) three times for ten minutes. Following this 
procedure the slices were kept in TBS (0.1M) exclusively until they were fixed in agar 
and cut into thinner, 50µm thick slices for staining. By using an inverted microscope 
with Epi-fluorescence attachment (Eclipse TS100, Nikon, Melville, NY, USA), slices 
containing the Lucifer Yellow (excitation 470nm) loaded glia cell were pre-selected 
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(Filter F36-525, HC Set, EGFP, AHF Analysetechnik AG, Tübingen, Germany). These 
slices were again washed for ten minutes in TBS (0.1M).  
In total, 8 slices were stained for GFAP (primary antibody: Polyclonal Rabbit Anti-Glial 
Fibrillary Acid Protein, Dako, Glostrup, Denmark; secondary antibody: Rhodamine Red 
–X conjugated AffiniPure Goat Anti-Rabbit lgG, Jacksonimmuno, Baltimore, USA). 
The first antibody anti-GFAP was diluted in 485µl TBS (0.1M) and 10µl Triton (10%). 
A maximal of 3 slices per microdish were incubated free-floating in this solution over 
night at 4°C. On day two, the slices were washed again (TBS three times for ten 
minutes) and stained with the second antibody gt anti-rb RRX (2.5µl) diluted in 485µl 
TBS (0.1M) and 10ml Triton (10%) for three hours. Finally, the washing procedure was 
performed a last time and the slices were mounted on a slide (Engelbrecht, Medizin- 
und Labortechnik GmbH, Edermünde, Germany) and covered with vectashield (Linaris, 
Dossenheim, Germany). To prepare the slices for scanning, they were covered 
(Coverslips, Labomedic, Bonn, Germany) and sealed 24 hours after with transparent 
nail polish. Astrocyte scans were performed with a confocal laser scanning microscope 
(Leica TCS NT, Leica Microsystems, Wetzlar Germany) and a 63x objective (Leica, 
1.20 W Corr CS). The voxelsize was 0.04 (width) x 0.04 (height) x 1.5µm (depth) and 
the total area of every scanned plane was 39.7 (width) x 39.7µm (height). The number 
of sections was dependent on the size of the cell. 
2.11.1 Analysis of immunhistochemical treated brain slices 
Images were displayed and processed with the Leica confocal scanning software (LCS 
lite, Leica) and Zeissviewer 3.5 (Carl Zeiss AG, Oberkochen, Germany). 
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3.1 Systematic analysis of presynaptic group II mGluR 
activation by synaptically released glutamate 
To systematically analyse presynaptic group II mGluR activation by synaptically 
released glutamate, medial perforant path fibres in the dentate gyrus of hippocampal rat 
brain slices were stimulated and the corresponding field potential was measured.  
A field potential (fEPSP) is an extracellular correlate to electrogenic processes within 
cells during potential changes and contains presynaptic (fibre volley) and postsynaptic 
(pspike) information. The presynaptic component reflects the temporal propagation of 
action potentials when passing the recording electrode. The postsynaptic component 
shows the summated response of dentate gyrus granule cells on presynaptic inputs. A 
positive fEPSP slope reflects a “source” (potential change to positive in the ECS and 
negative within the cell) and a negative slope a “sink” (positive potential in the cell and 
negative in the ECS).  
If presynaptic inhibitory group II metabotropic glutamate receptors (located at medial 
perforant path fibres in the DG) get activated during presynaptic stimulation, they 
depressed further release of glutamate. As a consequence, the postsynaptic component 
of a measured fEPSP decreased. To investigate group II mGluR activation 
systematically we applied burst stimulation protocols specific to every mGluR 
activation limiting factor. Furthermore we assessed the mGluR mediated inhibition on 
the fEPSP via the antagonist induced abolishment of the fEPSP depression.  
 
3.1.1 mGluR activation by spontaneous, stimulation independent 
glutamate release  
Strikingly, baseline fEPSP recordings with 100µM DL-TBOA showed a decrease in the 
fEPSP amplitude after application of the substance alone, which could be reversed by 
applying 3µM of the group II mGluR antagonist LY341495 (Figure 15A). To verify the 
assumption that a high DL-TBOA concentration causes an accumulation of glutamate, 
which is probably stimulation independent and leads in turn to an activation of group II 
3 Results 
mGluRs, we performed the following tests. We did paired pulse stimulation (stimulus 
length 0.1ms, inter-stimulus interval 40ms) and monitored the fEPSP response to the 
first pulse over time. After approximately 20 minutes of stable baseline we made a 
random decision between the conditions 1) stimulation break 2) stimulation break with 
100µM DL-TBOA and 3) 100µM DL-TBOA alone. The obtained data supported the 
assumption of stimulation independent mGluR activation during strong blockade of 
glial glutamate uptake (Figure 15B). Tests under condition 2) as well as under condition 
3) showed that during sustained 100µM DL-TBOA incubation, the fEPSP amplitude 
started to decline. Comparisons of averaged fEPSP amplitudes between time point “a“ 
(before substance application and/or stimulation break, normalized to 100%) and time 
point “b“ (after application and/or stimulation break) revealed a 19.9 ± 4.5% (n=5) 
decrease in fEPSP amplitude for condition 2) and a 16.3 ± 2.8% (n=5) decrease for 
condition 3) (Figure 15B). Experiments under condition 1) exhibited only normal 
fluctuations in baseline amplitude -0.1 ± 2.4% (n=5), except for the phase right after the 
stimulation break. The fEPSP amplitude was increased but declined relatively fast back 
to initial size. This effect can be explained by a refilling of the vesicle pool during the 
stimulation break. When stimulation continued, the amount of vesicles released was 
increased for a short period of time until the pool size restored to the level present 
during continuous paired pulse stimulation (Figure 15B). All in all the data showed that 
strong glutamate transporter blockade (100µM DL-TBOA) resulted most likely in an 
accumulation of spontaneously released glutamate. In order to avoid this effect, we had 
to lower the DL-TBOA concentration and repeated the experimental condition 3) with 
40µM DL-TBOA. The comparison of averaged fEPSP amplitudes before (“a”=100%) 
and after application (“b”) showed that the decline in fEPSP amplitude could be 
strongly reduced to a negligible degree (6.5 ± 41.7%, n=5, Figure 15C).  
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Figure 15.  Glutamate transporter blockade with 100µM DL-TBOA leads to accumulation 
of spontaneously released glutamate. (A) Normalized fEPSP amplitudes of one single 
experiment recorded in the MML. Averaged (n=4) fEPSP responses for three different time 
points (a, b, c) are magnified. Traces are normalized on the average peak amplitude before drug 
application (black, scaling: 0.5 norm, 5ms). fEPSP responses declined after 100µM DL-TBOA 
application and recovered during mGluR blockade with 3µM LY341495. (B) Normalized 
fEPSP amplitudes of three different experimental conditions: stimulation break (black), 
stimulation break + 100µM DL-TBOA (dark green), continuous stimulation + 100µM DL-
TBOA (light green). The upper part of the panel shows a comparison of single averaged fEPSP 
amplitudes (n=6): shortly before stimulation break (a, black), approximately 10 min after 
stimulation break respectively at the end of the experiment (b, red) (same scaling as in A). 
100µM DL-TBOA caused stimulation independent group II mGluR activation by accumulated, 
spontaneously released glutamate. (C) Normalized fEPSP amplitudes of one experimental 
condition. Application of 40µM DL-TBOA caused only a negligible decrease in fEPSP 
amplitude (same scaling as in A and B). 
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3.1.2 mGluR activation by stimulation induced synaptic release of 
glutamate  
3.1.2.1  Role of glutamate transporters 
In every experiment the same burst protocol was applied (7stim at 100Hz). The average 
percentage inhibition under non-facilitating conditions was weak (5.5 ± 0.9%, n=8), 
whereas 40µM DL-TBOA strengthened mGluR mediated inhibition of synaptic 
transmission (12.6 ± 1.3%, n=32). An increase to 100µM DL-TBOA slightly raised the 
effect (17 ± 2.4%, n=13, Figure 16A, B).  
Experiments performed with ACSF (-0.7 ± 1.2%, n=4) and 40µM DL-TBOA alone      
(-1.3 ± 1.7%, n=4) showed no significant difference in fEPSP response on the test-
stimulus indicating that in both stimulation rounds the amplitude of the fEPSP was 
approximately inhibited to the same extent (Figure 16B).   
A comparison between group II mGluR activation with the antagonist DCGIV (1µM) 
and stimulation induced mGluR activation under application of 100µM DL-TBOA 
illustrates the enormous discrepancy between a pharmacological and a synaptic 
mediated mGluR effect on synaptic transmission (Figure 16C). Whereas 
pharmacological activation leads to an approximately 80% depressed fEPSP amplitude 
(Figure 16C, left and upper right panel), activity induced mGluR activation causes a 
more than four times smaller depression of the fEPSP amplitude (Figure 16B, C lower 
right panel). 
To sum up, the results show that mGluR activation increases the more the glutamate 
uptake by astrocytes is limited and that the depression on the test fEPSP amplitude 
during burst stimulation is not due to synaptic plasticity. 
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Figure 16. Glutamate transporter blockade by DL-TBOA facilitates mGluR mediated 
inhibition of synaptic transmission. (A) fEPSPs recorded and stimulated (7stim at 100Hz) in 
the middle molecular layer (MML) of the dentate gyrus (DG). Example traces are from three 
single experiments (scaling: 0.5mV, 50ms). In the upper trace of each example mGluRs were 
activated and in the lower trace blocked by the antagonist LY341495. The magnified 
illustrations (dashed rectangle) show peak comparisons between fEPSP responses on the first 
test-stimulus for both conditions. Traces are normalized on the peak amplitude under 
antagonism (black, scaling: 0.5 norm, 5ms). The more glutamate transporters were blocked by 
DL-TBOA, the stronger was the mGluR mediated inhibition. (B) Summary bar graph showing 
the percentage of mGluR mediated inhibition of single fEPSPs after burst stimulation under 
different mGluR activating conditions. The inhibition was low without DL-TBOA and highest 
with 100µM DL-TBOA. Tests with ACSF or 40µM DL-TBOA alone showed no significant 
difference in mGluR mediated inhibition between the first and second round of stimulation. (C) 
Single example of pharmacological mGluR activation by 1µM DCGIV. The fEPSP amplitude 
was strongly depressed to approximately 20% (b, red) of its initial size (a, black) (left graph and 
peak comparison in upper right panel). In contrast, synaptic activation (7stim at 100Hz, 100µM 
DL-TBOA) of mGluRs results in a much weaker inhibitory effect (to ~87% of initial size, lower 
right panel). Example traces are normalized on the peak amplitude before drug application (top) 
or on the peak amplitude under antagonism (bottom) (scaling: 0.5norm, 5ms). 
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3.1.2.2 Role of GABA receptors 
To define the role of GABAA and GABAB receptors in feedback inhibition at medial 
perforant path synapses, the following experiments were performed.  
At first, a burst protocol (28stim at 100Hz) was given in the presence of NMDA 
receptor blocker DL-AP5 (25µM) and glutamate transporter blocker DL-TBOA (40µM) 
to prevent plasticity and to facilitate mGluR activation. To assess the degree of fEPSP 
amplitude depression mediated by group II mGluRs, the stimulation protocol was 
repeated under group II mGluR blockade with LY341495 (3µM). The resulting 
inhibition of the fEPSP amplitude was 14 ± 2.2%, (n=13, Figure 17A upper traces). 
Next, the experiment was performed as described before, but after stimulating (28stim 
at 100Hz) under 40µM DL-TBOA and 100µM DL-AP5 application, the slice was 
additionally incubated with the GABAA and GABAB receptor antagonists Bicucullin 
(10µM) and CGP (2µM) before repeating the stimulation protocol. Then, the group II 
mGluR blocker was added.  The stimulation protocol was applied one last time and the 
resulting fEPSP amplitude depression measured via the LY341495 mediated increase in 
fEPSP amplitude. The inhibition with additional GABA receptor blockade was 7.4 ± 
2.3% (n=4, Figure 17A lower traces).  
Statistical analysis showed no significant difference in fEPSP amplitude depression 
between both groups ((1) additional GABAA and GABAB receptor blockade and (2) 
DL-TBOA alone, p= 0.097, Figure 17B). To sum up, GABA receptors are not 
significantly involved in feedback inhibition at medial perforant path fibre terminals. 
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Figure 17. GABA receptors do not significantly contribute to LY341495 induced increase 
in fEPSP amplitude. (A) fEPSPs recorded and stimulated (28stim at 100Hz) in the MML. 
Example traces belong to two representative experiments (scaling: 0.5mV, 50ms). Group II 
mGluR activation is indicated in red, blockade with 3 µM LY341495 in black and in green 
GABAA and GABAB receptors were blocked additionally with 10µM bicucullin and 2µM CGP. 
On the right side, fEPSP responses on the first test-stimulus (dashed rectangle) are magnified 
and overlaid in each example experiment. Traces are normalized on the peak amplitude under 
antagonism (black, scaling: 0.5 norm, 5ms). The GABA receptor blockade did not attenuate the 
inhibition of synaptic transmission, indicating that the effect is predominantly mGluR mediated. 
(B) Summarized plot of the percentage mGluR of mediated inhibition on fEPSPs with and 
without GABA receptor blockade. The inhibition does not significantly differ between both 
groups (t-test, p= 0.097). 
 
 
3.1.3 mGluR activation depending on stimulation frequency  
To find out at which firing frequency of presynaptic perforant path neurons mGluR 
activation reached its maximum, stimulation protocols with varying stimulation 
frequency within a conditioning burst (5, 10, 20, 50, 100, 200Hz, Figure 18A, B) were 
designed. The length of the conditioning burst was 459 ± 26ms (n=5) and the time 
interval between conditioning burst and test-stimulus 200ms. mGluR activation was 
assessed as described in section 2.4.5.  
Stimulation with 3stim at 5Hz led to a slight mGluR mediated inhibition (4.3 ± 2.9%, 
n=5, Figure 18A, B) which more than doubled in strength after stimulation with 5stim at 
10Hz (10.2 ± 2.7%, n=3, Figure 18A, B). Applying the stimulation protocol 7stim or 
10stim at 20Hz slightly increased the effect to 11.5 ± 2.0% (data sets of 7 and 10stim at 
20Hz are averaged, n=7, Figure 18B). With the stimulation paradigms 25stim at 50Hz 
and 50stim, respectively 56stim at 100Hz the inhibition further increased to 16.6  ± 
3.9% (n=3, Figure 18B) and 18.5 ± 4.3% (data sets of 50 and 56stim at 20Hz are 
averaged, n=11, Figure 18A, B) and reached a maximum with the 100stim at 200Hz 
(22.7 ± 3.3, n=10, Figure 18A, B).  
To sum up, the data show that group II mGluR activation is strongly linked to the firing 
frequency of the presynaptic neurons.  
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Figure 18. Group II mGluR activation increases with firing frequency of presynaptic 
neurons. (A) Representative fEPSP traces recorded in the MML with four different stimulation 
paradigms (frequency variation in a fixed time window of 459 ± 26ms, scaling: 0.5mV, 
100ms). Highlighted are fEPSP responses on the first test-stimulus under group II mGluR 
activation (red) and blockade (black). Traces are normalized on the peak amplitude under 
antagonism  (black, scaling: 0.5 norm, 5ms). The group II mGluR mediated inhibition increased 
with frequency. (B) Summarized percentage inhibition of the fEPSP amplitude mediated by 
group II mGluRs plotted against stimulation frequency. The inhibition reached a maximum at 
100stim at 200Hz. 
69 
 
3 Results 
70 
 
3.1.4 mGluR activation dependence on duration of stimulation  
To unravel the meaning of the duration of medial perforant path fibre stimulation for 
group II mGluR activation, the following experiments were performed. The frequency 
of the applied conditioning burst was kept constant but the number of stimuli varied (1, 
3, 7, 14, 25, 28, 50, 56, 100, 200 at 100Hz, 0.2sec PBI, Figure 19A, B). The stimulation 
protocol was applied under mGluR activating conditions (40µM DL-TBOA) and 
mGluR blocking conditions (3µM LY341495) (time in between: 10min). For each 
protocol cycle, ratios were calculated between the response on the test-stimulus and the 
first peak fEPSP response of the conditioning burst. The first ratio was divided by the 
second ratio to determine the degree of mGluR mediated inhibition. In order to check 
whether burst stimulation induced long term depression at some point, the stimulation 
protocol was applied exclusively with ACSF (Figure 19B, grey trace). 
As expected, the stimulation protocol 1stim, 200ms post burst interval (PBI) was not 
sufficient to initiate mGluR activation (-0.3 ± 2.3%, n=7). Increasing the number of 
stimuli to 3 raised the mGluR mediated inhibition to 6.3 ± 3.3% (n=11, Figure 19B) and 
only a few stimuli more caused already a clearly detectable mGluR effect (14.1 ± 1.0%, 
n=29, 7stim at 100Hz, Figure 19A, B). Prolonging the burst to 14 stimuli caused a slight 
drop in the inhibition (11.5 ± 1.1%, n=12, Figure 19B) which was abolished again by 
giving the burst protocol 25stim or 28stim at 100Hz (14.0 ± 2.2%, data sets of 25 and 
28stim at 100Hz are averaged, n=13, Figure 19B). Application of 50stim or 56stim at 
100Hz led to an additional increase to 18.5 ± 4.3% (data sets of 50 and 56stim at 100Hz 
are averaged, n=11, Figure 19A, B) and the maximum activation was finally reached 
with 100stim at 100Hz (29.7 ± 5.8, n=9, Figure 19A, B). Prolonging the stimulation 
protocol to 200stim at 100Hz did not further raise the inhibition mediated by group II 
mGluRs (26.3 ± 4.2%, n=9, Figure 19B). Depending on the duration of stimulation the 
mGluR mediated inhibition on synaptic transmission increased with a time constant tau 
of 370 ± 190ms.  
Experiments with ACSF alone were performed for three stimulation paradigms (50, 100 
and 200stim at 100Hz) to test whether burst stimulation causes inhibition on synaptic 
transmission which is independent from group II mGluR activation. Stimulation with 
50stim at 100Hz and 100stim at 100Hz under these conditions revealed no further 
increase in inhibition of the fEPSP amplitude when applying the stimulation protocol a 
second time (-2.2 ± 6.3%, n=6 and -6.0 ± 5.3%, n=6). However, giving the protocol 
3 Results 
71 
 
200stim at 100Hz resulted in a stronger inhibition 21.8 ± 8.4% (n=6) after the second 
application. This indicated that activity dependent plasticity effects occurred, which was 
most probably an AMPA receptor desensitization during this high frequent train of 
activity (Figure 19B).  
To sum up, the data show that group II mGluR activation is strongly dependent on the 
number of stimuli and increases with sustained stimulation as long as vesicle supply is 
assured and no further plasticity initiated. 
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Figure 19. Prolonged presynaptic fibre activity strengthens group II mGluR activation. 
(A) Shown are four examples of fEPSP traces recorded in the MML (scaling: 0.5mV, 100ms). 
The stimulation frequency was kept constant and the number of stimuli varied. In each case the 
response on the first test-stimulus is enlarged. Compared are the fEPSP amplitudes under 
blockade of group II mGluRs (3µM  LY341495, black) and facilitated mGluR activation (40µM 
DL-TBOA, red). Traces are normalized on the peak amplitude under antagonism (black, 
scaling: 0.5 norm, 5ms). (B) Summary plot of percentage inhibition mediated by group II 
mGluRs as a function of stimuli number (left side). mGluR activation raised with increasing 
number of stimuli and reached a plateau at 100stim at 100Hz (black). Test with ACSF alone did 
not show an inhibitory effect until a certain number of stimuli was reached (grey). On the right 
side, the mGluR mediated inhibition of fEPSP amplitude is plotted versus duration of 
stimulation (black). The curve fit (red) revealed a time constant tau of 370 ± 190ms.  
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3.1.5 Time course of mGluR mediated feedback inhibition of synaptic 
transmission 
Next, it was important to look at the time course of group II mGluR activity and to 
answer the following questions: how long does it take to see a maximal mGluR effect 
and how long does it last? In order to describe it, mGluR activation was tested at 
different post burst intervals (PBI: 0.03, 0.05, 0.1, 0.2, 0.3, 0.5, 0.8, 1, 3, 6, 20s, Figure 
20A, B).  
At 0.03s PBI the mGluR mediated inhibitory effect on synaptic transmission was 2.4 ± 
5.4% (n=4) and raised up to 7.4 ± 4.3% (n=6) at 0.05s PBI. The inhibition further 
increased after 0.1s PBI (9.9 ± 2.2%, n=9) and reached its maximum at 0.2s PBI (12.8 ± 
1.2%, n=34). Prolonging the post burst interval further reversed the effect and the 
mGluR mediated inhibition on synaptic transmission started to decline (0.3s PBI, 10.5 ± 
3.3%, n=8). After 0.5s PBI 8.9 ± 1.6% (n=6) of the inhibitory effect was present and it 
was even detectable after 0.8s PBI (8.2 ± 1.2%, n=7). At 1s PBI the degree of inhibition 
dropped to 4.0 ± 1.4% (n=14) and reached after 3s a value of 2.4 ± 1.6% (n=12). After 
6s PBI the inhibitory effect on synaptic transmission did not significantly decrease 
anymore (2.0 ± 0.8%, n=17) and the last tested PBI (20s) revealed a residual inhibition 
of (0.0 ± 0.9%, n=8).  
For two different PBIs, experiments were performed with ACSF alone to check whether 
there was no difference in the degree of mGluR mediated inhibition between responses 
on test stimuli after applying the burst protocol a first and a second time (Figure 20B). 
This was true for 0.2s PBI (-0.7 ± 01.2%, n=4) as well as for 20s PBI (1.9 ± 1.0%, n=5).  
Fitting the time course of mGluR mediated inhibition revealed faster mGluR activation 
kinetics (tau= 40 ± 20ms) and slower deactivation kinetics (tau= 840 ± 230ms). 
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Figure 20. Group II mGluRs activate within 200ms and remain active for at least 800ms. 
(A) Illustrated are three fEPSP example traces recorded and stimulated (7stim at 100Hz) in the 
MML (scaling: 0.5mV, 50ms). The post burst interval (PBI) increases from top to bottom. The 
fEPSP response on the first test-stimulus under mGluR activation (red) and blockade (black) is 
magnified (right panel). ). Traces are normalized on the peak amplitude under antagonism 
(black, scaling: 0.5 norm, 5ms).  (B) Average plot of percentage inhibition on synaptic 
transmission mediated by group II mGluRs depending on PBI (black) with a curve fit displayed 
in red. The inhibition reached its maximum after 200ms PBI (tau activation= 40ms ± 20ms) and 
was still detectable after 800ms (tau deactivation= 840 ± 230ms). Experiments with ACSF 
alone showed no mGluR mediated inhibition (green).  
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3.1.6 Influence of repetitive burst stimulation on mGluR activation 
The maximum mGluR mediated inhibition on synaptic transmission was reached during 
receptor activation by synaptically released glutamate after applying the conditioning 
burst protocol 100stim at 100Hz (29.7 ± 5.8%, n=9, Figure 19A, B) under mGluR 
activation facilitating conditions (40µM DL-TBOA). This degree of inhibition was still 
far away from the strength of depression induced by pharmacological mGluR activation 
(≥ 80%, Figure 16C).  
We assumed that group II mGluRs started to deactivate before they fully activated. If 
the vesicle pool depleted during continuous burst stimulation, less glutamate was 
released. Potentially, a smaller amount of transmitter had a chance to overcome the 
homeostasis between release and removal to keep mGluRs activated or to further 
increase the degree of receptor activation, respectively.  
To allow vesicle pool refilling, we started using a stimulation protocol composed of 
repetitive bursts with different inter burst intervals (IBI, 0.05s, 0.3s, 0.5s) and varying 
number of stimuli (2, 3, 7) and frequency (50Hz, 100Hz) within the burst. In every 
experiment the repetitive burst stimulation protocol was applied two times, under A) 
mGluR activating (DL-TBOA 40µM) and B) under mGluR blocking (LY341495 3µM) 
conditions.  
For the analysis of each given protocol, the peak amplitude of the first fEPSP response 
to each burst and to the first test-stimulus subsequent to bursting was determined. Then, 
ratios were calculated by comparing these amplitudes with the response on the first 
stimulus in the very first burst. The ratios for condition A) were divided by the 
corresponding ratios for condition B) to calculate the degree of group II mGluR 
mediated inhibition on the fEPSP amplitudes.  
In order to test whether group II mGluR activation increases with repetitive burst 
stimulation, we started with the protocol 4x7stim at 100Hz (0.5sec IBI, 0.2s PBI, Figure 
21A). However, instead of increasing, the mGluR mediated inhibition declined after the 
second burst and reached only a maximum of 14.6 ± 2.7% (n=6, see asterisk in example 
one Figure 21A). Perhaps, the IBI was too long for cumulative mGluR activation and 
the receptors already reached a deactivated state between the bursts.  
Next, we shortened the inter burst interval and adjusted the number of stimuli within a 
burst in order to optimize vesicle release and refilling during repetitive bursting. 
Moreover, the number of repetitions was increased (10x2stim at 100Hz, 0.05sec IBI, 
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0.2sec PBI, Figure 21A). This time the mGluR mediated inhibition raised while bursting 
but the maximum gained inhibitory effect was smaller than before (6.4 ± 5.0%, n=4, see 
asterisk in example two Figure 21A). We assumed, that the inter burst interval was 
perhaps too small as well as the stimulation frequency within a burst, still causing a 
strong depletion of the vesicle pool.  
As a consequence, we lowered the frequency and increased the IBI again. To complete 
the design of the stimulation protocol, I added one more stimulus to a burst and 
increased the total number of bursts (15x3stim at 50Hz, 0.3sec IBI, Figure 21A). 
However, despite the changes, even this repetitive burst protocol did not generate any 
increase in mGluR mediated inhibition (14.6 ± 3.3%, n=4, see asterisk in example three 
Figure 21A).  
To sum up, no cumulative effect on mGluR activation by repetitive burst stimulation 
could be shown.  
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Figure 21. Repetitive burst stimulation does not potentiate mGluR mediated feedback 
inhibition. Example fEPSP traces from three different repetitive burst stimulation experiments 
in the MML associated with the percentage mGluR mediated inhibition on the first fEPSP 
response of every burst in the stimulation protocol (scaling: 0.5mV, 200ms). The maximum 
inhibited fEPSP amplitude is marked by an asterisk. Highlighted is the maximum inhibited field 
potential response (red) compared with the response on the very first stimulus (black). Traces 
are normalized on the peak amplitude under antagonism (black, scaling: 0.5 norm, 5ms). None 
of the tested stimulation protocols caused a summation of the group II mGluR mediated 
inhibitory effect that significantly differs in strength from values obtained in single burst 
experiments.  
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3.2 Presynaptic Ca2+ imaging as a tool to directly assess 
presynaptic inhibition 
At this point, the most interesting findings on group II mGluRs were that the receptor 
mediated inhibitory effect on synaptic transmission developed with a time-constant tau 
between 40 ± 20ms (Figure 20B) and 370 ± 190ms (Figure 19B), disappeared slower 
with a time constant of 840 ± 230ms (Figure 20B) and reached a lower maximum (29.7 
± 5.8%, n=9, Figure 19A, B) compared to pharmacological conditions (~80%, Figure 
16C), even under glutamate transporter blockade (40µM DL-TBOA).  
We decided to investigate the kinetics of group II mGluR mediated inhibitory action on 
synaptic transmission in more detail in order to find out at which time point 1) the group 
II mGluR activation causes first inhibitory effects (latency) 2) synaptic transmission is 
maximally depressed by mGluR activity and 3) the mGlu receptor deactivation ends and 
the strength of synaptic transmission is back at initial level before mGluR action. 
The presynaptic Ca2+ signal was the best readout for this purpose because mGluR 
activation causes a signal cascade that leads to an inhibition of presynaptic N- or P/Q-
type voltage-gated Ca2+channels (Chavis et al., 1994, McCool et al., 1996, Takahashi et 
al., 1996, Robbe et al., 2002), which is in turn directly coupled to the neurotransmitter 
release machinery (Spafford and Zamponi, 2003), meaning that the depression of the 
presynaptic Ca2+ signal reflected a nearly simultaneous depression of glutamate release.  
3.2.1 Loading of MPP fibres with an AM ester Ca2+ indicator dye  
As described in section 2.5.2, I selectively loaded medial perforant path fibres with an 
acetoxy-methyl (AM) ester form of a membrane-permeable fluorescent Ca2+ indicator 
(either Magnesium Green AM or Oregon Green Bapta-1 AM) via positive pressure 
injection (Figure 22A, top) and waited 20 to 40 minutes until the fibre tract was 
sufficiently loaded. The fluorescence F was detected by illuminating the slice with 
470nm light. After 20 minutes of heating the bath up to 35°C to measure at 
physiological temperature (in the meantime the fluorescence F further intensified and 
stabilized at the end) the stimulation pipette was placed distal to the injection site and 
the pinhole (defines the region of interest (ROI)) distal to the tip of the stimulation 
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pipette (Figure 22A, middle). During stimulation of the MPP the fluorescence increased 
by ∆F (Figure 22A, bottom).  
First of all, I had to check, whether the Ca2+ signal monitored in the MML was of 
presynaptic origin. Therefore I performed calcium imaging experiments during wash-in 
of the AMPA receptor blocker CNQX (30µM). Postsynaptic AMPA receptors 
predominantly mediate fast synaptic transmission which is also Ca2+ dependent. If the 
Ca2+ signal contained a postsynaptic component, the ∆F peak amplitude would have 
become smaller in the presence of CNQX. In the first ten minutes after application there 
was no change in amplitude detectable compared to the Ca2+ signal under ACSF alone 
(ACSF: 1.4 ± 0.1%, npoints=6, CNQX: 1.4 ± 0.0%, npoints=6; Figure 22B, black and grey 
trace). The slight decrease was due to a continuous run-down of the signal during the 
experiments (see comparison between the black and grey trace, Figure 22B, left panel 
and Ca2+ peak comparison between “a” (black) and “b” (red), Figure 22B, right panel). 
When the sodium channel blocker TTX (1µM) was added, action potential generation 
during presynaptic stimulation was prevented and the calcium signal started to 
disappear, and it was finally gone after a few minutes (0.0 ± 0.1%, npoints=6, Figure 22B, 
green trace). This additionally supports the previous result, meaning that a Ca2+ signal 
detected was mostly presynaptic in origin. However, a certain fraction of postsynaptic 
involvement can never be excluded completely.  
To sum up, our experiments provided evidence that specifically the medial perforant 
path fibre tract with its presynaptic terminals was loaded and not its postsynaptic 
counterparts (dendritic spines of granule cells). 
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Figure 22. The Ca2+ signal is of presynaptic origin. (A) Section of the hippocampal dentate 
gyrus (top) shown in the differential interference contrast (DIC) mode. The border between 
granule cell, inner-, middle- and outer molecular layer is indicated by a dashed line. The border 
of the dentate gyrus is marked by a continous line. Medial perforant path fibres are loaded with 
a fluorescent calcium indicator (here: Oregon Green 488 BAPTA-1 AM, middle). Illuminating 
the slice with 470 (bandwidth ±30nm) light results in fluorescence F. Stimulation of the MPP 
fibre tract leads to a calcium influx causing a fluorescence increase by ∆F (bottom) (scaling: 
30µm). Changes in fluorescence were detected within a defined region (square) of the MPP 
fibre tract. (B) The inset shows a normalized, averaged calcium signal over time. Whereas the 
calcium signal amplitude was unaffected by CNQX (30µM), the application of TTX (1µM) 
caused a tremendous decrease. Illustrated on the right side is an overlay of calcium signal 
averages from three different time points (a, b, c; n= 6, scaling: 0.013 F norm, 40ms). 
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3.2.2 Pharmacological group II mGluR activation depresses the Ca2+ 
signal amplitude  
Next, it was important to test if presynaptic group II mGluR activation really affects the 
presynaptic Ca2+ signal. Again, I recorded Ca2+ signals induced by MPP stimulation and 
used the low affinity Ca2+ indicator Magnesium green AM.  
After 10 minutes of baseline recoding in the presence of CNQX (30µM) and DL-AP5 
(30µM), I added the selective group II mGluR orthosteric agonist DCGIV (1µM), which 
binds on the active site of the receptor. As a result, the presynaptic Ca2+ signal 
decreased to 63.4 ± 5.0% (“b”, average of npoints=4) compared to the amplitude (“a”, 
average of npoints=4) before application of DCGIV (Figure 23A).  
In contrast, the group II mGluR antagonist LY341495 abolished the effect of DCGIV 
and the Ca2+ signal recovered back to baseline (Figure 23A). Slight deviations from the 
initial size are due to a run-down during the experiments.  
In summary, the tests showed that pharmacological group II mGluR activation 
negatively affected the size of the presynaptic Ca2+ signal.  
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Figure 23. Activation of group II mGluRs by DCGIV causes a decrease in calcium signal 
amplitude. Shown is the temporal change of normalized, averaged calcium signal amplitudes 
depending on group II mGluR activation (DCGIV 1µM) respectively blockade (LY341495 
3µM). MPP fibres were loaded with the low affinity calcium indicator Magnesium Green AM. 
Pharmacological activation by DCGIV almost caused a bisection of the calcium signal size 
which could be completely reversed by LY341495 mediated antagonism. The right side of the 
inset shows averaged Ca2+ signals (n= 6) of three different time points (a, b, c, scaling: 0.01 F 
norm, 2.5ms).  
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3.2.3 Influence of glutamate uncaging induced mGluR activation on Ca2+ 
signal amplitude 
So far, the experiments affirmed that the presynaptic Ca2+ readout seemed to be an 
appropriate way to assess the activation and deactivation kinetics of the presynaptic 
inhibitory feedback process. The last step to clarify was, whether exposing the 
metabotropic glutamate receptors to the endogenous ligand glutamate causes activation 
as well.  
We decided to perform glutamate uncaging instead of synaptic stimulation because the 
essential advantage of this technique is a direct and constant exposure of the freed 
ligand to the receptor. In contrast, synaptically released glutamate can underlie plasticity 
and varies in concentration. However, before we finally used this method, we had to 
find out whether uncaged glutamate effectively activated presynaptic group II mGluRs 
and caused a depression of the presynaptic Ca2+ signal of assessable size. 
In principle, the experimental procedure could be described as follows (see also section 
2.10). First, a calcium indicator loaded MPP fibre tract was stimulated with a pre- 
stimulus, followed by UV laser uncaging and a test-stimulus (inter stimulus interval 
(ISI) ~ 1s) and the corresponding Ca2+ signal response on the pre- and test-stimulus was 
monitored (Pinhole, Figure 24A). A pre-stimulus was applied to get a reference Ca2+ 
signal reflecting the unaffected state before mGluR activation. The Ca2+ response on the 
test-stimulus after uncaging of glutamate displayed the state after mGluR activation. If 
group II mGluRs activated, the response on the test-stimulus should have been 
depressed. However, a part of the depression might not only be due to mGluR activation 
but also arising from plasticity at the synapses. Therefore, in the second part of the 
protocol, only a pre- and test-stimulus were applied (Figure 24A) and ratios were 
calculated between the peak amplitude on the test-stimulus and pre-stimulus for the first 
as well as the second part of the protocol. Then the ratio for the first part (with 
uncaging) was divided by the ratio for the second part (without uncaging) to extract the 
quotient of inhibition of the calcium transient.  
To provide evidence, that the inhibition is due to group II mGluR activation, the 
previous experimental series was also performed under wash-in of group II mGluR 
antagonist LY341495 (3µM).  
The data showed that mGluR activation via uncaging caused an integral depression of 
the calcium signal by 11.5 ± 0.0% (n=4) Figure 24B), however less pronounced as 
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under pharmacological activation (36.6 ± 5.0%, average of npoints=4, Figure 23A, “b” 
left panel).  
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Figure 24. Glutamate uncaging induced group II mGluR activation in the MML causes 
presynaptic calcium signal depression. (A) Schematic illustration of a combined imaging and 
uncaging protocol (scaling: 40µm). The upper right snapshot shows a calcium indicator dye 
(Magnesium Green AM) loaded MPP fibre tract exited with 470nm (bandwidth ±30nm) light. 
The aperture (area of calcium signal detection) is positioned close to the tip of the stimulation 
pipette. The uncaging spot is centered to the middle of the pinhole. The following experimental 
procedure is described by an alternating protocol starting with a combination of pre-stimulus, 
UV laser mediated uncaging and test-stimulus followed by a pre- and test-stimulus alone. 
During stimulation, calcium signals were measured and peak ratios were calculated and 
compared ((Teststimuncaging/ Prestimuncaging)/ (Teststim/ Prestim)) (scaling: 0.02 F norm, 2.5ms). 
(B) Comparison of averaged percentage inhibition of calcium signal amplitudes between: 
mGluRs activated by caged glutamate and mGluRs blocked by LY341495 (3µM). Similar to 
pharmacological activation but less pronounced, activation of group II mGluRs by uncaged 
glutamate (250µM) caused a reduction in calcium signal size which could be inverted by 3µM 
LY341495.  
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3.3 Assessing the time course of extracellular glutamate 
during uncaging 
In order to describe the kinetics of group II metabotropic glutamate receptors as exactly 
as possible, conditions that disturbed the activation and deactivation process, e.g. a 
fluctuating glutamate concentration, had to be avoided. The aim was to create a UV 
laser protocol that produces a nearly rectangular glutamate concentration in the 
extracellular space, in other words, a fast increase of free glutamate, followed by a 
maintaining of the prevailing concentration and a fast drop after uncaging. In order to 
determine how the glutamate concentration varied during uncaging, we made use of 
processes directly coupled to glutamate uptake by astrocytes. The uptake rate is 
proportional to the change in extracellular glutamate. 
3.3.1  Method 1: Voltage sensitive dye imaging with RH155 
The first method tested was voltage sensitive dye (VSD) imaging. VSDs bind to the 
external surface of cell membranes without interrupting their normal function and act as 
molecular transducers that transform changes in membrane potential in an optical signal 
with a high temporal resolution. The VSD we used was RH155 which preferentially 
stains glia cells over neurons. Medial perforant path fibres in a RH155 stained slice 
were stimulated with the protocol 5stim at100Hz to cause synaptic glutamate release. 
The optical VSD signal arising from astrocyte membrane potential changes during 
electrogenic glutamate uptake was monitored. Tests were performed in the presence of 
the AMPA receptor blocker CNQX (30µM) because in addition to glutamate 
transporters also AMPA receptors are expressed in astrocytes (Seifert et al., 1997) and 
glutamate induced AMPA receptor currents were not in the focus of interest.  
After CNQX application the VSD signal amplitude decreased to 76.4% of its initial size 
(Figure 25A). In order to check whether the VSD signal seen was due to glutamate 
transporter current induced changes in astrocyte membrane potential, we performed the 
synaptic stimulation experiment under wash-in of 40µM DL-TBOA to block glutamate 
transporters. As a result of this, the VSD signal strongly suppressed to 16.8% (Figure 
25A).   
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In general, the size of the observed VSD signal during stimulation was smaller than 
expected from literature (Kojima et al., 1999). We assumed that light absorption of the 
tissue could be a limiting factor for voltage sensitive dye imaging with RH155. In order 
to shed light on this, I determined the spectral values for unstained and stained slices 
between approximately 400 and 700nm wavelength (Figure 25B).  
We measure the intensity of visible light passing stained and unstained tissue with and 
without band-pass filter between 400 and 700nm and divided the value obtained with a 
filter (Figure 25B, right, red trace) by the value gained without the band-pass filter   
(Figure 25B, right, red trace). The relative absorption intensity exhibited two peaks for 
the unstained as well as the stained slice, one around 530nm and the second one around 
700nm (Figure 25B, left graph). The latter turned out to be very problematic, because in 
the VSD imaging experiments the light absorption changes caused by RH155 were also 
detected at 700nm (filter: F35-700 Versa Chrome HC 700/ 13). 
Another problem occurred, when we tried to uncage glutamate and image the RH155 
signal at the same time. We used a beam splitter (reflection 330-485nm >90%, 
transmission 505-700nm >90%) together with a second filter (F39-409 Brightline HC 
409/ LP) to exclude the UV light from the optical signal. However, we could detect an 
optical signal during uncaging, reflecting rather the time course of uncaging (Figure 
25C, left, black trace) instead of a VSD signal time course corresponding to astrocyte 
membrane potential changes during glutamate uptake (Figure 25C, left, red trace: 
synaptic stimulation induce VSD signal). An explanation might be, that the UV light 
excited the voltage sensitive dye RH155, leading to a strong fluorescence detected at 
700nm (bandwidth ±13nm).  
Summarized, the optical properties of the slice and the voltage sensitive dye RH155 
under UV illumination made the combinatory approach (glutamate uncaging and VSD 
imaging) impossible to use for our purpose.  
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Figure 25. Voltage sensitive dye imaging with RH155 is not suited to detect astrocyte 
membrane potential changes during glutamate uncaging. (A) VSD imaging in the MML of 
the dentate gyrus during synaptic stimulation of the MPP fibre tract. Slices were loaded with 
RH155, preferentially staining glial cells, and illuminated with visible light. Optical signals 
were detected at 700nm (bandwidth ±13nm). Changes in glial membrane potential are indicated 
by an absorption increase. Whereas 30µM CNQX hardly affected the VSD signal, 40µM DL-
TBOA almost completely abolished it. The baseline (before stimulation) is normalized to 1 
(scaling: 0.001 norm, 0.1s). (B) Summary plot of absorption values for different wavelength in a 
stained and unstained slice. The relative absorption intensity was calculated as follows: optical 
signalband pass filter / optical signal no filter. The relative absorption intensity exhibited two peaks 
within the tested wavelength range. The first peak value approximately at 530nm was higher for 
the unstained slice and the second peak at 700nm for the stained slice (scaling: 0.5V, 0.005s). 
(C) Optical signal of RH155 stained slice during UV stimulation (black) and during synaptic 
stimulation (red).  
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3.3.2 Method 2: Measuring astrocyte glutamate transporter currents 
The second technique I applied was the measurement of astrocyte glutamate transporter 
currents directly during glutamate uncaging while whole cell patch clamping the 
astroglial cell (Figure 26A, filled with lucifer yellow).  
Sodium dependent glutamate transporters are responsible for removing released 
glutamate from the extracellular space (Anderson and Swanson, 2000, Danbolt, 2001, 
Gadea and Lopez-Colome, 2001) and the transporter current displays a linearly filtered 
representation of glutamate clearance (Bergles et al., 1997, Diamond, 2005). Due to the 
translocation of net positive charge during each transport cycle, it was possible to 
monitor the transport electrophysiologically. Measuring glutamate uptake during flash 
photolysis of caged glutamate did not display a problem because it has been shown that 
stimulation as well as uncaging induced glutamate transporter transients exhibited 
similar kinetics (Diamond, 2005).  
In general, astroglial glutamate transporters exhibits rapid kinetics and are capable of 
binding glutamate on a sub-millisecond timescale (Figure 26B), similar to the binding 
rates estimated for ionotropic glutamate receptors (Bergles et al., 1997). 
Immuncytochemical studies demonstrated that GLAST and GLT-1 are glutamate 
transporter types mainly expressed in astrocytes. GLAST predominates in the 
cerebellum and GLT-1 in the cerebral cortex and hippocampus (Lehre et al., 1995, 
Lehre and Danbolt, 1998). Astrocytes were identified by sulforhodamine 101 labelling 
(see section 2.9.2) (Nimmerjahn et al., 2004) and GFAP staining (Figure 26C) (Eng, 
1985) as well as by their passive membrane properties (Figure 26D) (Bergles and Jahr, 
1997).  
When we started to perform glutamate uncaging and glutamate transporter current 
measurements simultaneously, the experiments showed, that the time course of 
glutamate transporter transients was strongly dependent on the laser pulse length and 
frequency and on pharmacology, especially DL-TBOA (Figure 26E, F). It was 
important to find the right interplay between laser pulse length and frequency under a 
certain DL-TBOA exposure to create a nearly rectangular glutamate transporter current 
and extracellular glutamate concentration gradient, respectively. Figure 14E displays 
two examples of transporter currents exhibiting suboptimal time courses during 
uncaging. In contrast, the last example (Figure 26F) shows the most suited, nearly 
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rectangular looking glutamate transporter current obtained by eliciting a long followed 
by a series of shorter UV laser flashlights in the presence of 40µM DL-TBOA. 
We continued to use the latter UV stimulation protocol for combinatory Ca2+ imaging 
and glutamate uncaging experiments in order to investigate the kinetics of the 
presynaptic group II mGluR mediated inhibitory process in detail.  
However, the slowed transporter current decay (tau= 440ms) was unavoidable after 
uncaging. It took approximately 800ms until the transient recovered to the resting level 
before uncaging.  None of the changes we tried to prevent this worked out well. Testing 
the involvement of other receptor types revealed neither NMDA receptor blockers 
(100µM DL-AP5, MK 801 50µM), AMPA receptor blockers (CNQX 30µM or NBQX 
10µM) nor mGluR1 (LY367385 50µM) and mGluR5 blockers (MPEP 10µM) had a 
fastening effect on the decay. Also an increase in laser spot size did not cause any 
change. The only parameters affecting the kinetics of the decay were the duration of UV 
laser pulsing and the DL-TBOA concentration. The longer the UV stimulation and the 
higher the DL-TBOA concentration the more prominent the decay was slowed. 
However, we had to activate group II mGluRs to an assessable extent, meaning that we 
needed a certain minimum duration of uncaging as well as DL-TBOA to facilitate 
mGluR activation. All in all, the range of possibilities was small to circumvent our 
problem. 
 
88 
 
tau= 10ms
400
 20 pA
10ms
UV stim
0.02 s
 2e-09 A 2n
2 ms
LY  GFAP
A B
C D
                    
3 Results 
1x50ms (ISI 6ms), 8x6ms (ISI 30ms)
4000
 10 0pA
.2s
1x30ms (ISI 2ms), 23x6ms (ISI 6ms)
4000
 10 0pA
.2s
1x12ms (ISI 1ms), 20x5ms (ISI 12ms)E
F
No DL-TBOA
 Control 
 100µM cGlut
 
 
DL-TBOA 10µM
 Control 
 100µM cGlut
 
0.2 s
 10 pA 
tau= 440ms
DL-TBOA 40µM
 Control
 cGlut 250µM
 fit_decay
UV stim
UV stim
UV stim
 
Figure 26. Astrocyte glutamate transporter current profile is strongly dependent on 
pharmacology and the UV laser uncaging protocol. (A) Patch clamped astrocyte (scaling 
10µm) in whole cell mode filled with Lucifer yellow (1%). (B) Example of an astroglial   
transporter current caused by 10ms uncaging of glutamate (vertical bar; scaling: 20pA, 10ms). 
(C) Lucifer yellow labelled astrocyte which is GFAP+ (scaling 20µm). (D) Whole cell current 
pattern of an astrocyte (scaling: 2nA, 20ms). From a holding potential between -80 and -90mV 
cells were depolarized in steps of 10mV up to +20mV. (E) Glutamate transporter current pattern 
depending on the glutamate uncaging protocol and the used DL-TBOA concentrations (red, 
scaling: 10pA, 50ms). Control traces without caged glutamate are labelled in black. Particularly 
the glutamate transporter blocker DL-TBOA strongly slowed the current and the onset of the 
current was faster than the decay after uncaging. (F) The ideal glutamate transporter current 
during uncaging was more or less “step-like” to reach a constant glutamate concentration in the 
extracellular space while uncaging. The time constant (tau) for the decay after uncaging was 
440ms. The decay (red) was fitted (green) to the mean baseline current between the black and 
the red trace after uncaging (dashed line). 
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3.4 Receptor kinetics of presynaptic group II mGluRs  
In the following experimental series we investigated the kinetics of presynaptic group II 
mGluRs in detail. For this purpose we performed glutamate uncaging together with 
presynaptic Ca2+ imaging and assessed group II mGluR activation via uncaging-induced 
inhibition of presynaptic Ca2+ transients. 
3.4.1 Latency and activation kinetics  
For the assessment of latency and activation kinetics we exposed group II mGluRs to 
uncaged glutamate (γ-CNB-caged L-glutamic acid 250µM) for varying duration in the 
presence of following drugs: DL-TBOA 40µM, NBQX 10µM and DL-APV 100µM 
(Figure 16A). The glutamate transporter blocker DL-TBOA was used to facilitate group 
II mGluR activation and the AMPA receptor blocker NBQX as well as the NMDA 
receptor blocker DL-AP5 were applied to prevent postsynaptic Ca2+ signals and 
influences on the presynaptic Ca2+ transient.  
For the experimental series, the combinatory Ca2+ imaging and uncaging protocol     
described in section 2.10 was used. The uncaging protocol was based on the protocol 
shown in Figure 26F. The degree of uncaging induced Ca2+ transient inhibition was 
obtained by calculating ratios between the Ca2+ signal response on the test-stimulus  and 
the Ca2+ signal response on the pre-stimulus and dividing the ratio for the first part (with 
uncaging) of the combinatory protocol by the ratio for the second part (without 
uncaging). The same experiments were performed under wash-in of the group II mGluR 
antagonist LY341495 (3µM) and the resulting inhibition on the presynaptic Ca2+ 
transient mediated by group II mGluRs was determined via the antagonist mediated 
increase in  the Ca2+ signal amplitude. 
To resolve the onset of mGluR mediated presynaptic Ca2+ transient inhibition, we 
started with a short uncaging protocol (1x20ms UVstim; Figure 27A, upper left UV 
stimulation protocol) and imaged the calcium signal after 32ms post uncaging interval 
(PUI). The resulting inhibition was 4.0 ± 1.1% (n=4, Figure 27A). Next, we prolonged 
the UV laser protocol by increasing the duration of the first long laser pulse and added a 
series of shorter laser pulses with a defined inter stimulus interval (ISI) (1x50ms 
UVstim (ISI 6ms), 2x6ms UVstim (ISI 30ms), PUI 32ms; Figure 27A, upper right UV 
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stimulation protocol). As a result, we monitored an increase in presynaptic Ca2+ 
transient inhibition (9.3 ± 3.5%, n=3, Figure 27A). The inhibition further rose with 
increasing duration of uncaging (15.8 ± 2.7%, n=3; 1x50ms UVstim (ISI 6ms), 7x6ms 
UVstim (ISI 30ms), PUI 32ms) and reached its maximum after approximately 450ms of 
uncaging (16.7 ± 2.5%, n=3, 1x50ms UVstim (ISI 6ms), 11x6ms UVstim (ISI 30ms), 
PUI 32ms, Figure 27A). The time constant (tau) for the activation kinetics was 150 ± 
30ms (Figure 27A). Experiments with the antagonist LY341495 were performed using 
the shortest (1x20ms UVstim, PUI 32ms) and the longest laser protocol (1x50ms 
UVstim (ISI 6ms), 11x6ms (ISI 30ms), PUI 32ms) resulting in 3.5 ± 0.6% (n=3) and 2.8 
± 0.6% (n=2) inhibition (Figure 27A). 
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Figure 27. Activation kinetics of presynaptic group II mGluRs. Summary plot of percentage 
inhibition of the Ca2+ signal amplitude depending on glutamate exposure time (black). The 
curve fit is displayed in red. Within 450ms of glutamate uncaging, group II mGluRs fully 
activated (tau= 150 ± 30ms). Under blockade with 3µM LY341495 inhibition of the Ca2+ 
transient was missing (grey, average: green). On top of the graph, representative examples of 
Ca2+ peak comparisons (black: without uncaging, no mGluR activation; red: with uncaging, 
mGlurs activated) for the first and last exposure time are shown (scaling: 0.02 F norm, 10ms). 
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3.4.2 Deactivation kinetics 
To determine the deactivation kinetics of group II mGluRs we monitored the recovery 
of the presynaptic Ca2+ transient after glutamate uncaging induced depression. During 
the experiments, the slices were exposed to 40µM DL-TBOA to block partially 
glutamate uptake in order to facilitate group II mGluR activation and additionally to 
30µM CNQX and 30µM DL-APV to block AMPA as well as NMDA receptors and 
prevent postsynaptic Ca2+ signals. For the experimental series we used again the 
combinatory Ca2+ imaging (dye: Magnesium Green AM) and uncaging protocol 
described in detail in section 2.10.  
First, we applied an uncaging protocol (1x20ms UVstim (ISI 3ms), 40x4ms UVstim 
(ISI 3ms); Figure 28A, upper UV stimulation protocol) to maximally activate group II 
mGluRs by freed glutamate (100µM γ-CNB-caged L-glutamic acid). Right after 
uncaging (post uncaging interval 60ms) the inhibition of the Ca2+ signal was strong 
(16.5 ± 9.0%, n=4, Figure 28A). Then, we prolonged the post uncaging interval (PUI) 
but kept the duration of uncaging constant. The inhibition of the Ca2+ signal declined 
after 600ms PUI to 10.8 ± 4.2% (n=5), and after 2000ms PUI 2.7 ± 4.4% (n=3) 
inhibition was detected (Figure 28A). The time constant (tau) for this decay was 1870 ± 
60ms.  
Experiments with the antagonist LY341495 (3µM) confirmed that the resulting Ca2+ 
transient inhibition was mGluR mediated. The inhibition could be completely blocked 
after 60ms PUI (-4.2 ± 1.7%, n=3) and 2000ms PUI (-5.0± 13.7%, n=2, Figure 28A).  
As described in section 3.3.2, the decline of the transporter current after glutamate    
uncaging was slow (tau= 440ms, Figure 26F). A consequence of this slowed astrocyte 
glutamate reuptake was a persistently elevated glutamate concentration in the 
extracellular space. This was not a problem when resolving the activation kinetics of 
group II mGluRs because only the constant exposure to glutamate during uncaging was 
important. However, for the deactivation kinetics a persistently elevated glutamate 
concentration turned out to be critical. It was important to clarify to which extent this 
slowed reuptake influences the real group II mGluR receptors kinetics.  
We developed an uncaging protocol causing a glutamate transporter current that 
matched the course of the slowed glutamate transporter transient, which occurred after 
applying the laser protocol which was described first in this section (Figure 28A, lower 
UV stimulation protocol). We tested, whether the amount of freed glutamate during this 
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protocol was enough to activate group II mGluRs. The experiments were performed 
under application of AMPA receptor (10µM NBQX) and NMDA receptor blockers 
(100µM DL-AP5, 50µM MK801), glutamate transporter blocker DL-TBOA (40µM), as 
well as with mGluR5 and mGluR1 (group I) antagonists (10µM MPEP, 50µM 
LY367385) and the sodium channel blocker TTX (1µM). The γ-CNB-caged L-glutamic 
acid concentration used was 250µM.  
The resulting inhibition was 4.3 ± 0.5% (n=2), which could be blocked by LY341495 
3µM (1.0 ± 0.0%, n=2, Figure 28A). Consequently, we assumed that the prevailing 
glutamate concentration during the slowed reuptake was enough to keep some mGluRs 
activated, which probably explains approximately 3.3% of the inhibition after 540ms 
PUI (Figure 28A). We also assumed, that the decay of the inhibition is mainly a 
representation of group II mGluR deactivation but partially also of mGluR activation. 
Insofar, the first experimental series provides rather a rough upper estimation on group 
II mGluR receptors kinetics. 
The next step was to design a UV laser protocol that sufficiently activates mGluRs but 
does not cause a slow glutamate concentration time course after uncaging in order to 
make a lower estimation about the deactivation kinetics of group II mGluRs.  
In combined astrocyte patch clamp and glutamate uncaging experiments we could 
observe that a relative short laser protocol (< 50ms UVstim) elicited no slowed decay. 
Moreover, we decided to abstain from DL-TBOA which additionally slowed the decay 
of the transporter transient and we used the high affinity Ca2+ indicator OGB1 AM 
because the bigger Ca2+ signal size and the better signal to noise ratio made it easier to 
detect small differences in Ca2+ signal amplitude. γ-CNB-caged L-glutamic acid was 
used in a concentration of 250µM. The uncaging protocol (20ms UVstim (ISI 6ms), 
2x6ms UVstim (ISI 6ms)) was applied in the presence of the AMPA and NMDA 
receptor blocker NBQX (10µM) and DL-AP5 (100µM) (Figure 28B).  
The inhibition monitored 109ms after uncaging, was small (7.3 ± 0.6%, n=4, Figure 
28B). After 259ms PUI the inhibition decreased to 4.9 ± 0.7% (n=4) and dropped to 1.7 
± 0.4% (n=6) after 409ms PUI (Figure 28B). However, after 559ms PUI the inhibition 
increased again (2.3 ± 0.7%, n=6, Figure 28B).  
We fitted the data to the average inhibition (2.3 ± 0.7%, n=4) obtained in the group II 
mGluR antagonization series with LY341495 (3µM) and calculated 150 ± 110ms for 
the time constant tau (Figure 28B). The big error was due to the high variability in the 
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data set, certainly arising to a great extent by activating group II mGluRs at a very low 
level. Because the weaker the mGluR mediated inhibition of the Ca2+ transient, the 
more difficult is it to determine the exact size if the inhibitory effect. 
To sum up, the described two experimental series provide an upper and a lower 
estimation for the group II mGluR deactivation kinetics to contain the temporal range of 
receptor deactivation. 
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Figure 28. Persistent glutamate due to slow glutamate reuptake after uncaging possibly 
interferes with mGluR deactivation. (A) Summarized graph of percentage inhibition of the 
Ca2+ signal amplitude depending on post uncaging time. On top of the panel, schematic 
drawings and example traces of used UV laser uncaging protocols are illustrated (upper: “step-
like“ with slow decay component, lower: only slow component).When testing different post 
uncaging intervals after applying the “step-like“ uncaging protocol with the slow decay 
component after uncaging, the ∆F peak amplitude slowly recovered back to its initial size before 
mGluR activation (red: curve fit, tau= 1870 ± 60ms). Testing the slow component-protocol to 
mimic the slow decay after uncaging, revealed presence of mGlu receptor activation, indicating 
a delayed deactivation of group II mGluRs when applying the “step-like“-protocol. Grey 
indicates averaged values of experiments performed under blockade of group II mGluRs with 
3µM LY341495 to set the threshold for mGluR activation (green). Representative Ca2+ peak 
(Magnesium Green AM) comparisons (black: without uncaging, no mGluR activation; red: with 
uncaging, mGlurs activated) at two different post uncaging intervals are shown (scaling: 0.02 F 
norm, 10ms) (B) Summarized graph illustrating the recovery of inhibited Ca2+ signal amplitude 
after group II mGluR activation with a short glutamate uncaging protocol (top). Here, in 
contrast to (A), the decay of the mGluR effect was much faster (red: curve fit, tau 150 ± 
110ms). Two Ca2+ peak (OGB1 AM) comparisons for two representative time points were 
selected (scaling: 0.17 F norm, 10ms).  
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3.5 Collaborative work 
3.5.1 Does mGluR8 activation affect vesicle refilling in lateral perforant 
path terminals? 
In general, presynaptic metabotropic glutamate receptors are believed and have been 
shown to inhibit synaptic transmission via blockade of presynaptic Ca2+ influx (Yoshino 
and Kamiya, 1995, Takahashi et al., 1996, Pinheiro and Mulle, 2008). However, there 
are many ways of modulating glutamate release. Apart from the reduction of Ca2+ entry 
by inhibition of calcium channels or activation of K+ channels, different parts of the 
release machinery could be directly influenced through presynaptic mGluR activity.  
So far, evidence was provided that certain mGluR subtypes mediate such a secondary 
effect downstream of Ca2+ entry (Scanziani et al., 1995, Tyler and Lovinger, 1995). In 
this study, the transduction target of mGluR8 was analyzed and it could be shown that 
this receptor inhibits transmitter release without affecting Ca2+ entry. Moreover, 
suggestions about the functional properties were made which could be affected by 
modulatory mGluR8 activity.  
The field potential experiments we performed for this study concentrated on answering 
the following question: is the synaptic transmission during sustained trains of activity 
higher during mGluR8 activation than during inhibition of voltage-gated calcium 
channels? For this purpose, we compared repetitive synaptic responses when 
transmission was depressed to the same degree either by the mGluR8 agonist PPG 
(3µM) or by the low affinity Ca2+ channel antagonist Co2+ (600µM). Co2+ blocked but 
did not permeate Ca2+ channels and depressed fEPSPs to 56.0 ± 1.0% (n=11) similar to 
PPG (58.5 ± 2.0%, n=9, Figure 29A-C). When a steady depression of the fEPSP was 
reached, we stimulated lateral perforant path fibres with the protocol 35stim at 25Hz. In 
both cases, a pronounced transient facilitation of synaptic transmission due to a 
decreased release probability initially occurred (Figure 29A-C, third pulse; PPG: 159.2 
± 3.9%, n= 9; Co2+: 155.3 ± 4.3%, n=11). The facilitation declined fast, probably, 
because the vesicle supply became a limiting factor. Conspicuously, after approximately 
250ms (first 5 – 7 stimuli), the fEPSP responses under Co2+ became clearly smaller 
whereas in the presence of PPG larger amplitudes were maintained. At the end of the 
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train the amplitudes reached 84.9 ± 5.5% and 67.3 ± 4.1% under PPG and Co2+. These 
results supported the assumption that mGluR8 activity does not affect Ca2+ entry.  
The conclusion of the whole study was that mGluR8 mediated inhibition might be 
explained by a decrease in the apparent Ca2+ affinity of the release sensor and, to a 
smaller extent, by a reduction of the maximal release rate. 
 
Figure 29. Inhibition of release by mGluR8 allows for a higher potency of transmission 
during sustained trains of activity. This figure is reproduced from Erdmann et al. (2011). (A) 
Reduction of the first fEPSP in the train of stimulations by 3 µM PPG (left panel) (scaling: 
0.2mV, 5ms). Response to a train of action potentials evoked by 35 stim at 25Hz (right panel). 
After the initial facilitation there was only a slight decline of the amplitudes roughly back the 
amplitude of the first fEPSP (scaling: 0.1mV, 0.1s). (B) Same experiment as in A but performed 
with Co2+ instead of PPG. Co2+ concentration was adjusted to achieve an identical inhibition of 
synaptic transmission when compared to PPG (600µM, see left panel). After the initial 
facilitation of transmission amplitudes of fEPSPs strongly declined to a value substantially 
below the one of the first pulse (Right panel). Scaling as in A. (C) Summary of experiments 
performed as shown in A and B. Under activation of mGluR8 there was a stronger synaptic 
potency during the late phase of the train. (D) Summary of percentage inhibition of single 
fEPSPs caused by PPG and Co2+  in the experiments shown in A to C.  
97 
 
3 Results 
98 
 
3.5.2 Does frequency facilitation at mossy fibres synchronously go along 
with an increase in Ca2+ influx? 
Frequency facilitation, elicited by low-frequency stimulation (LFS) is a specific 
property of mossy fiber–CA3 synapses. The CA3 region responds to LFS with potent 
enhancement of evoked responses (Salin et al., 1996, Toth et al., 2000, Nicoll and 
Schmitz, 2005).  
So far, it is still unclear how this phenomenon is generated, which factors are involved 
and how these factors act together. For a study dealing with potential mechanisms 
controlling frequency facilitation, we performed presynaptic Ca2+ imaging experiments 
on hippocampal mossy fibres.  
In principle, the augmentation of transmitter release during frequency facilitation could 
be due to an increase in local free Ca2+ concentration at the Ca2+ sensor for vesicle 
fusion via an increased Ca2+ influx. In order to test this assumption, we loaded mossy 
fibres in acute mouse brain slices with the low affinity Ca2+ indicator Magnesium green 
AM and imaged presynaptic intra-terminal Ca2+ transients during LFS (6x10stim at 
1Hz, ∆ t between stimulation protocol application= 9s, Figure 30A-D). However, we 
could not detect any increase in Ca2+ influx (Figure 30C, D) during stimulation (all Ca2+ 
signals are normalized on the first of the train, 1st: 1 ± 0.0∆F norm; 10th: 0.97 ± 0.0∆F 
norm, n=5, Figure 30D).  
All in all, the data show that the presynaptic Ca2+entry is not affected during low 
frequency stimulation. Therefore, it can be excluded as possible mechanism controlling 
frequency facilitation.  
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Figure 30. The peak intra-terminal Ca2+ level within mossy fibres does not increase during 
1Hz facilitation. (A) Mossy fibres loaded with the fluorescent Ca2+ indicator Magnesium Green 
AM (scaling: 20µm). Optical signals were detected within a pinhole (dashed square) which was 
positioned in front of the pipette tip distal to the injection site. (B) Representative example of 
peak fluorescence (∆F) during MF stimulation (asterisk) (scaling: 0.005 norm F, 20ms). (C) 
Averaged Ca2+ signals normalized on the first peak of ten in total. The graph shows every third 
peak beginning with the first. Stimulation is indicated by an asterisk and the time interval 
between two peaks is 1s (scaling: 0.008 norm F, 100ms). (D) The inset shows normalized Ca2+ 
signal amplitudes plotted versus stimulus number. The peak fluorescence underlay slight 
fluctuations but did not increase with sustained stimulation. 
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4 Discussion 
4.1 Limiting factors of presynaptic inhibitory group II mGluR 
activation 
To date, very few studies have dealt with the activation or presynaptic inhibitory group 
II mGluRs by synaptically released glutamate (Scanziani et al., 1997, Dube and 
Marshall, 2000, Awatramani and Slaughter, 2001, Kew et al., 2001). In this studies, we 
tied in with these findings and continued testing the synaptic recruitment of presynaptic 
inhibitory group II mGluR by performing field potential recordings in the middle 
molecular layer of the rat hippocampal dentate gyrus. The reason why we have chosen 
this region is mainly explained by two important facts. The terminal field of the 
perforant path in the middle molecular layer of the dentate gyrus exhibits a high 
expression level of group II mGluRs as revealed by immunhistochemistry (Neki et al., 
1996, Petralia et al., 1996, Shigemoto et al., 1997, Ohishi et al., 1998) and 
autoradiographic studies (Mutel et al., 1998, Schaffhauser et al., 1998). Apart from that, 
medial perforant path fibres are highly laminar organized (McNaughton, 1980, Witter, 
2007) which made them very well suited for field potential recordings as well as 
presynaptic Ca2+ imaging. 
In agreement with the above mentioned studies, moderate burst stimulation of medial 
perforant path fibres caused a relatively weak group II mGluR mediated inhibition of 
synaptic transmission. To facilitate mGluR activation and to make it more assessable, 
we used a glutamate transporter blocker DL-TBOA causing a stronger accumulation of 
glutamate in the extracellular space (Takayasu et al., 2004). The use of 40µM DL-
TBOA more than doubled the mGluR mediated inhibitory effect which further 
increased with the application of 100µM DL-TBOA. This huge potentiating effect on 
group II mGluRs activation made clear that glial glutamate uptake is an important 
limiting factor in this respect.  
In addition to strengthening mGlu receptor activation during burst stimulation, 100µM 
DL-TBOA caused an inhibition of baseline transmission independent from stimulation. 
We suggest an activation of pre-terminal group II mGluRs by spontaneously released 
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glutamate during strong transporter blockade indicating that the receptor activation by 
the endogenous ligand is not necessarily coupled to firing of the presynaptic neurons 
they are located on. To allow controlled group II mGluR activation via burst 
stimulation, the side-effect had to be reduced to a negligible degree by lowering the DL-
TBOA concentration ending up with 40µM.  
In the past it has been indicated, that presynaptic group II mGluR activation increases 
with the frequency of synaptic stimulation (Scanziani et al., 1997). We systematically 
tested this at medial perforant path fibres and confirmed an mGluR effect clearly 
integrating the firing frequency of the presynaptic neuron. This was also true for the 
duration of stimulation. The mGluR mediated inhibitory effect on transmitter release 
became stronger until a plateau was reached after a few hundred milliseconds of 
stimulation. Circumstances that might have led to this limitation were, for example, a 
limited vesicle supply during high frequent synaptic stimulation (Model et al., 1975, 
Fernandez-Alfonso and Ryan, 2004). The exocytosis rate was higher than the 
endocytosis rate, leading to a continuous depletion of the vesicle pool. Probably at some 
point, the amount of vesicles released was too small to increase the degree of mGluR 
activation. Another factor that might have limited mGluR activation is AMPA receptor 
desensitization. It is known that high frequent activity can cause an AMPA receptor 
state in which the ligand no longer causes the receptor channel to open (Arai and Lynch, 
1998). The inhibitory modulatory effect of presynaptic group II mGluRs might have got 
restricted by the capacity of ionotropic AMPA receptors on the postsynaptic site. 
NMDA receptors did not need to be taken into account because all experiments were 
performed under blockade of these receptors. As another factor, one cannot rule out that 
maximum possible group II mGlu receptor occupation had already been reached. 
Glutamate clearance mechanisms like uptake and diffusion always keep the amount of 
available glutamate in the extracellular limited (Min et al., 1998, Huang and Bergles, 
2004), restricting group II mGlu receptor activation as well. 
Subsequently, we determined the time course of action on synaptic transmission. The 
onset of the effect was relatively fast and the maximum inhibition was reached after a 
few hundred milliseconds (100-300ms). In contrast, the decline was slow and lasted 
hundreds to thousands of milliseconds before the inhibition finally disappeared. This is 
consistent with findings about the kinetics of class C G-protein coupled GABAB 
receptors at parallel fibre to Purkinje cell synapse in cerebellar slices (Dittman and 
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Regehr, 1997). Whereas activation of presynaptic group II mGluRs is tightly controlled 
by the spatiotemporal profile of glutamate diffusion following exocytosis, the 
deactivation process is indicated to be driven by intrinsic receptor and signal cascade 
kinetics. 
So far, the maximum endogenous inhibition achieved had been still far beyond the 
inhibition reached by pharmacological activation of mGluRs by DCG IV (Yoshino et 
al., 1996). Possibly, the amount of released glutamate was not sufficient enough to fully 
activate presynaptic group II mGluRs or to keep the receptors activated, respectively. 
We hypothesized, repetitive burst firing (Larson and Lynch, 1988) mimics to a certain 
extent oscillatory firing pattern in the entorhinal cortex (Bragin et al., 1995, Paulsen and 
Sejnowski, 2000, Buzsaki, 2002) and that it potentially causes a temporal summation of 
released glutamate and potentiates receptor activation. For this purpose, an alternating 
protocol was designed that was composed of bursts to release transmitter and a break 
between each burst, only long enough to get the vesicle pool refilled before the 
transmitter (released before) completely diffused away. However, we could not observe 
any cumulative mGluR effect on synaptic transmission during repeated burst 
application.  
To summarise, none of the tested stimulation protocols caused an effect comparable in 
size to pharmacological induced inhibition, suggesting that the functional significance 
might not be determined by the degree of inhibition but rather by the long persistence of 
inhibition on synaptic transmission consistent with the finding about GABAB receptors 
(Pfrieger et al., 1994, Dittman and Regehr, 1997) and feedback inhibition in general 
(Kupchik et al., 2011).  
4.1.1 Performing field potential recordings to systematically investigate 
group II mGluR activation 
The performance of field potential recordings displayed the most simple and most 
effective way to study group II mGluR activation direct and systematically. Group II 
mGluRs are distinctively and numerously distributed at the terminals of highly dense 
and parallel medial perforant path fibres (Hjorth-Simonsen and Jeune, 1972, Shigemoto 
et al., 1997). Due to a specific paired pulse plasticity (paired pulse depression) 
(McNaughton, 1980) and the nearly perfect laminar arrangement of the MPP fibre tract 
which forms excitatory synaptic contacts with granule cell dendrites it was possible to 
4 Discussion 
103 
 
selectively stimulate the MPP fibre tract and record the corresponding postsynaptic 
response of granule cell dendritic spines with less experimental effort. mGluR activation 
during MPP burst stimulation was indicated by a decrease of the postsynaptic response 
and could be directly assessed after the experiment. Each presynaptic limiting factor 
(duration of activity, frequency of activity, pattern of activity) and other group II 
mGluR activation influencing factors (glutamate uptake by astrocytes, GABAergic 
inhibition of synaptic transmission), as well as the time course of mGluR action on 
synaptic transmission could be determined separately via applying appropriate 
stimulation protocols. To not run the risk of causing long term plasticity during high 
frequent stimulation, NMDA receptor blockers were used and a restriction of mGluR 
activation due to fast glutamate removal was avoided by lowering the glutamate uptake 
by astrocytes with the glutamate transporter blocker DL-TBOA.  
It was disadvantageous, that these manipulations created an environment less 
physiological in favour of an inhibitory mGluR effect of assessable size. Another 
critical factor to be taken into account is that field potentials can only be used to get 
rough approximations about intracellular events. Especially peak measures of field 
EPSPs at high stimulation intensity can be contaminated with pspikes (potentials 
corresponding to the action potential), pIPSPs (or population IPSPs) and polysynaptic 
events. Moreover, one could argue that in vitro experiments in general have less 
physiological validity. However, investigations have to start at some point and 
experiments, e.g. on brain slices often provide important insights, helpful for future 
experimental series in vivo.    
Despite critical points, this technique permitted a robust screening of mGluR activation 
in order to make progress in finding out how and when these receptors activate and 
which mechanism might significantly control this process. 
 
4.2 Kinetics of presynaptic group II mGluR mediated 
inhibition 
Activation of presynaptic voltage gated calcium channels results in a rapid triggering of 
vesicle fusion and release (Sabatini and Regehr, 1996). Consequently, an inhibition of 
presynaptic Ca2+ influx, for example by a metabotropic glutamate receptor induced 
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signal cascade (Takahashi et al., 1996), results in a direct depression of transmitter 
release. The activation of presynaptic group II mGluRs induces a Gi/o dependent internal 
signal cascade which in turn negatively affects the presynaptic, action potential 
dependent Ca2+ signal of P/Q-type voltage gated calcium channels (Chavis et al., 1994, 
Pin and Duvoisin, 1995). The time course, starting with receptor activation and ending 
with the calcium influx directly acting on the release machinery reflects the onset of 
mGluR mediated inhibition of synaptic transmission. To resolve the temporal dynamics 
of presynaptic group II mGluR induced depression and to shed light on the question 
whether the temporal dynamics of the inhibitory effect is shaped predominantly by the 
uptake and diffusion of glutamate or rather by the intrinsic kinetics of the mGlu receptor 
mediated signalling process within the presynaptic terminal, we performed Ca2+ 
imaging at presynaptic medial perforant path terminals and measured the action 
potential triggered Ca2+ influx via the transient increase in indicator fluorescence 
(Sabatini and Regehr, 1995). In combination with Ca2+ imaging, UV laser uncaging of 
glutamate was performed to selectively activate or deactivate group II mGluRs, 
respectively. 
The onset of the mGluR effect and the time to reach maximum inhibition (200-300ms) 
were comparable to the results obtained when group II mGluRs were activated 
synaptically (see Figure 20). The determination of group II mGluR deactivation kinetics 
turned out to be problematic. As mentioned later on (section 4.2.4), the glutamate 
uptake by astrocytes was delayed after uncaging with a UV laser stimulation protocol, 
originally designed to cause a nearly rectangular glutamate concentration in the 
extracellular space during uncaging.   
In general, glutamate is cleared away very fast after synaptic release by diffusion 
(~1ms) (Clements et al., 1992, Clements, 1996, Wahl et al., 1996, Diamond, 2005), 
through binding by glutamate transporters on a sub-millisecond time scale  (Diamond 
and Jahr, 1997) and by glutamate uptake (>10ms) (Bergles et al., 1997, Bergles and 
Jahr, 1997).  
Strikingly, in our experiments we observed that longer exposure of a patched astrocyte 
to uncaged glutamate slowed the decay of the glutamate transporter current. This 
suggest that glutamate transporters close to the uncaging spot were saturated by the 
endogenous ligand, forcing glutamate to diffuse a longer distance to find farther 
available sites. Potentially, cell damage caused by the UV laser or the activation of other 
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channels could also account for this slow decay. But, none of the changes like 
increasing the size of the uncaging spot, dampening the UV laser with neutral density 
filters, lowering the caged glutamate concentration, nor the blockade of several types of 
receptors and channels (AMPAR, NMDAR, group I mGluRs, sodium channels) 
potentially affecting the current, led to a significant change. Tests with a “slow-
component“ UV laser protocol, mimicking the time course of the transporter current 
occurring after uncaging with the previous describe protocol, confirmed that the amount 
of glutamate present after applying a “step-like“ protocol is still potent enough to keep 
at least a few mGluRs active. Thus, the rapid removal of glutamate from the 
extracellular space after flash photolysis was an essential condition for a reliable 
conclusion concerning the time course of deactivation we were not able to manage. One 
could argue, that the slowed reuptake is an effect which also appears under 
physiological conditions when presynaptic neurons are highly active, causing a 
saturation of glutamate transporters which in turn supports ongoing mGluR receptor 
occupancy. But, this is speculative and not yet shown. Unfortunately, the suboptimal 
conditions only allowed making an upper and a lower estimation about the deactivation 
kinetics.  
For the upper estimation a long-lasting uncaging protocol and DL-TBOA (40µM) was 
used to activate group II mGluRs maximally, but we had to take into account that the 
time course of inhibition after uncaging reflects interplay between deactivation and 
activation, the former to a greater extent than the latter. Interestingly, the upper 
estimation (tau ~1800ms) revealed a timescale well fitting the duration of fEPSP 
recovery after synaptically activated mGluRs (see Figure 20). In both cases the 
inhibition lasted up to a few seconds (~2s) before it became un-assessable.  
The lower estimation was made using a short uncaging protocol and no DL-TBOA to 
prevent interference by a slowed reuptake. In contrast to the previous result, the 
inhibitory effect declined much faster (tau ~150ms) and was already gone after 
approximately 400ms. However, the total inhibition was weak and the assessibility 
limited due to the high variability in the data set.  
If we suggest, that the real duration of group II mGluR deactivation is somewhere in 
between lower and upper estimation, the process is indicated to be rather long lasting. 
This in turn strongly supports the assumption, that the deactivation is controlled by 
intrinsic slow receptor kinetics rather that extracellular glutamate dynamics. If the 
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deactivation was be dependent on receptor occupation with the ligand glutamate and 
follow its temporal decline in concentration during diffusion and glial uptake, the 
process would be much faster. 
Although we were restricted to approximations, the data strongly support the suggestion 
that presynaptic group II mGluRs rather mediate a weak and persistent inhibition as it 
was shown for another metabotropic (class C) G-protein coupled receptor (Dittman and 
Regehr, 1997) and indicated for the mGluR1 subtype in cultured PC12 cells (Marcaggi 
et al., 2009). 
4.2.1 Using Ca2+ imaging as a tool to assess the dynamics of mGluR 
mediated inhibition  
To resolve the kinetics of presynaptic group II mGluR mediated inhibition, we had to 
measure the presynaptic Ca2+ transient peak amplitude at different mGluR activity 
states. It would have been complicated to measure presynaptic Ca2+ currents in patch 
clamp experiments because medial perforant path terminals are very small. An easier 
way to measure Ca2+ transients was the usage of a fluorescent indicator specific for Ca2+ 
(Sabatini and Regehr, 1998). In our imaging experiments, we used acetoxy-methyl 
(AM) ester derivates of fluorescent indicators (Magnesium green AM, OGB-1 AM). 
Fluorescent indicators are derivatives of the Ca2+ chelators EGTA, APTRA and 
BAPTA. Masking carboxylic acids of the chelator with AM ester groups results in an 
uncharged lipophilic molecule that can permeate cell membranes. Within the cell, the 
lipophilic blocking AM esters groups get cleaved by intracellular esterases resulting in a 
charged form that leaks out of the cell whereas the impermeable polycarboxylate stays 
in the cell. The hydrolysis of the esterified groups is essential for binding the target. The 
fluorescent Ca2+ indicators described here operate at visible wavelength and binding of 
Ca2+ leads to a change in fluorescence emission intensity. An advantage of AM-linked 
Ca2+ indicator dyes is that, for example, cellular compartments can be selectively 
labelled. It was challenging to find out, if medial perforant path fibres could really be 
loaded with a fluorescent Ca2+ indicator via pressure injection because these fibres are 
myelinated and it was not clear whether the loading would be selective enough. 
Fortunately, it turned out to work and we started optically monitoring stimulation 
induced presynaptic Ca2+ transients before and after presynaptic group II mGluR 
activation.  
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Ca2+ indicators are characterized by their binding affinity reflected in the dissociation 
constant Kd. Most experiments were performed with the low affinity Ca2+ indicator 
Magnesium green AM. Lower affinity indicators are suited for measuring Ca2+ in 
cellular compartments with higher concentrations (like presynaptic terminals during 
action potential triggered Ca2+ influx) and these indicators can also be used to measure 
rapid changes in Ca2+. Due to their low affinity for Ca2+, the kinetics of the reactions are 
rapid enough to analyze Ca2+ alterations with high temporal resolution. For our purpose, 
this was advantageous because we wanted to resolve fine changes in Ca2+ signal size at 
certain time points after glutamate uncaging induced mGluR activation. However, the 
relatively small Ca2+ signal size (approximately 2-4%) was disadvantageous, causing 
suboptimal signal to noise ratios. In a single experiment, stimulation paradigms had to 
be repeated and the corresponding data points averaged to prevent high variability. In 
contrast, high affinity indicators like OGB-1 AM produced a much bigger Ca2+ signal 
and showed a better signal to noise ratio but these dyes may also buffer intracellular 
Ca2+. Moreover, due to their high-affinity, they saturate at relatively low levels and 
errors in the Ca2+estimation can occur. 
In the end, it had to be pondered which Ca2+ indicator suited best for the corresponding 
experimental series to create most optimal conditions.  
4.2.2 Using flash photolysis to expose mGluRs to glutamate  
For the temporal resolution of the dynamic inhibitory process mediated by presynaptic 
group II mGluRs in situ it was important to bring glutamate directly to the receptor and 
to create constant conditions during activation. Flash photolysis of caged glutamate 
provided several advantages compared to synaptically released glutamate and this 
method has been already successfully tested, for example in a study about GABAB 
receptor kinetics (Dittman and Regehr, 1997) and in a variety of cellular and circuit 
level processes in the last decades (Callaway and Katz, 1993, Nikolenko et al., 2007). 
Whereas burst stimulation of presynaptic fibres causes an indefinite glutamate 
concentration due to a spatial gradient of glutamate after release and a naturally 
occurring depletion of the vesicle pool, light activation of glutamate allows a controlled 
delivery of glutamate with temporal and spatial precision. Moreover, synaptic release 
underlies a certain plasticity which does not occur during uncaging. Another important 
advantage of glutamate uncaging is that the concentration of the caged ligand is known 
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before flash photolysis and conclusions about the temporal changes in the amount of 
glutamate in the extracellular space during uncaging can be made by detecting astrocyte 
glutamate transporter currents. In this study, γ-CNB-caged L-glutamic acid was chosen 
because an illumination of this photo-activatable derivate with 355nm light resulted in a 
rapid, highly localized release of the freed neurotransmitter glutamate at the site of 
illumination. However, there are limitations to the caged compound that can be used. 
Typically 1- 2% gets spontaneously uncaged and if high concentrations are used it is 
likely that high affinity receptors get activated before UV laser uncaging (Dittman and 
Regehr, 1997, Ellis-Davies, 2007). Despite this restriction, it can be concluded that 
uncaging of glutamate was best suited to expose presynaptic group II mGluRs directly 
to the endogenous ligand with a constant concentration over a definite time. This 
allowed resolving the activation and deactivation kinetics of the mGluR mediated 
inhibitory process in detail because diffusion times and changing glutamate levels could 
be prevented. 
4.2.3 Applying voltage sensitive dye imaging to assess extracellular 
glutamate levels during uncaging 
To verify the temporal course of freed glutamate during uncaging, we first came up with 
the idea to optically monitor uncaging induced glutamate transport. The advantage was 
that it did not require a reconstruction of the setup and the technique of voltage sensitive 
imaging was relatively easy to apply. The plan was to stain preferentially astrocytes 
with the voltage-sensitive dye RH155. When glutamate transporters activated, the glial 
membrane potential changed and the VSD responded with a change in absorption. In 
preliminary work we could show a stimulation induced VSD signal which was of glial 
origin because a blockade of glutamate transporters (40 or 100µM DL-TBOA) 
abolished it. Next we wanted to uncage glutamate and monitor the corresponding VSD 
signal simultaneously. However, this did not work out well. We observed an increase in 
optical signal intensity following the time course of uncaging instead of a decrease 
which was expected as a result of RH155 absorption increase during glutamate 
uncaging induced astrocyte membrane potential changes. An explanation would be that 
UV light excited the voltage sensitive dye RH155, leading to an emission at the 
wavelength range (~700nm) where originally the VSD signal itself should have been 
detected. Besides, the calculation of absorption values for a defined wavelength range 
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under stained and unstained conditions revealed tissue absorption intensity peaking at 
two different wavelengths, approximately at 530nm and at 700nm additionally 
disturbing the detection of an absolute RH155 signal. All in all, this combinatory 
approach turned out to be impracticable. 
4.2.4 Performing glutamate transporter current measurements on 
astrocytes during flash photolysis to evaluate extracellular 
glutamate levels 
The measurement of astrocyte glutamate transporter currents is a successfully tested 
way to estimate the concentration time course of extracellular glutamate (Bergles et al., 
1997, Bergles and Jahr, 1997). Moreover, it could be shown that synaptically released 
glutamate is taken up at the same rate as glutamate released via flash photolysis, 
indicating that the time course of clearance is not affected by the spatial location of 
transporters to the site of glutamate release (Diamond, 2005). In order to verify the 
temporal change of glutamate during uncaging at physiological temperature (35°C), we 
patch clamped astrocytes. Successfully patched astrocytes were kept in whole cell 
configuration and the current was monitored in voltage clamp mode. A disadvantage 
was that the relative expensive caged glutamate had to be added by perfusion because in 
preliminary tests it turned out that local bath application accompanied by a perfusion 
stop led to drastically temperature changes affecting the glial glutamate uptake which is 
highly temperature dependent (Asztely et al., 1997).  
Apart from the lastly mentioned disadvantage, measuring glutamate transporter currents 
is an absolute useful way to get information about the temporal course of freed 
glutamate during uncaging which was mandatory for us in order to design usable UV 
laser protocols.  
 
4.3 Pharmacological activation of mGluRs versus 
endogenous activation by glutamate 
Pharmacological activation of presynaptic inhibitory group II mGluRs has been 
extensively tested in the past decades (Dietrich et al., 1997, Kilbride et al., 1998, 
Bradley et al., 2000, Capogna, 2004, Doherty et al., 2004). The strong inhibition of 
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synaptic transmission induced by agonist binding together with the high affinity of these 
extra-synaptically located receptors (Pin and Duvoisin, 1995) let many to suggest an 
auto-regulatory role for presynaptic group II mGluRs (Macek et al., 1996, Conn and 
Pin, 1997, Cochilla and Alford, 1998) and an important functional role in many 
neuronal processes (Nakanishi, 1992, Conn and Pin, 1997, Niswender and Conn, 2010). 
Although a few studies already identified an obvious discrepancy between 
pharmacological and synaptic activation by released glutamate (Scanziani et al., 1997, 
Kew et al., 2001, Kilbride et al., 2001, Price et al., 2005), it has never been focused on it 
in detail. Our systematic analysis aimed to shed light on this antilogy. In fact, our results 
provide evidence for a real difference between pharmacological mGluR activation and 
activation by the endogenous ligand glutamate. Using the potent agonist DCGIV 
(affinity at mGluR 2/3 200 - 300nM (Conn and Pin, 1997)) resulted in a strong 
inhibition of synaptic transmission (~80%, Figure 16C). In contrast, the maximum 
inhibition reached by glutamate (affinity at mGluR in the micro molar range 4 – 20µM 
(Conn and Pin, 1997)) was only about 30% (Figure 19B) despite extensive testing of a 
variety of stimulation paradigms within the physiological range (Paulsen and 
Sejnowski, 2000) and beyond.  
The molecular basis for the high affinity and selectivity of DCGIV is mediated in part 
by an interaction between a third carboxylic acid group on DCGIV not present in the 
glutamate molecule and a tyrosine and arginine present in the binding pocket of group II 
mGlu receptors (Yao et al., 2003). An assumption explaining the different effect on 
synaptic transmission after pharmacological agonist binding and glutamate binding to 
group II mGluRs could be that the ligand binding domains (LBD) in the dimeric mGlu 
receptor show allosteric properties, however, only in the case of glutamate binding. As 
it has been shown for mGluR 1 (Suzuki et al., 2004) it could be that in terms of subunit-
subunit communication it comes to a negative cooperativity, meaning that binding of 
glutamate to one LBD weakens the binding of a second glutamate molecule to the other 
LBD. Contrary to glutamate, the strong affinity of DCGIV may overcome the weak 
binding conformation and achieves also to bind on the second LBD or binding of 
DCGIV to a LBD in general does not cause allosteric effects. A possible role for 
negative cooperativity in receptor function is to extend the glutamate concentration 
range to which the receptor can respond which would be useful for example in 
situations where continuous activity at synapses takes place. The receptor would be able 
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to respond because the ligand binding sites are not completely saturated. Another 
advantage would be a greater sensitivity for a lower ligand concentration.   
Despite this obvious discrepancy in inhibitory strength during pharmacological and 
synaptic or uncaging induced group II mGluR activation by glutamate, the integral 
inhibition on network activity mediated by group II mGluRs could be the same 
compared to a receptor mediating a direct and strong effect on synaptic transmission, 
because evidence is provided that the inhibitory group II mGluR effect is long lasting. 
In other words, the total inhibition does not necessarily differ between a fast and strong 
and a weak and continuing inhibition, meaning that the latter could be as effective as the 
first. 
 
4.4 How and when could presynaptic inhibitory group II 
mGluRs activate under physiological conditions? 
To understand glutamatergic modulation by presynaptic inhibitory group II mGluRs at 
medial perforant path terminals, morphological determinants as well as extrinsic and 
intrinsic factors have to be considered. The complexity of this scenario is immense, 
however it is worthwhile consider it to find potential answers on unsolved secrets. 
Medial perforant path fibre terminals form axo-spinous asymmetric synapses at granule 
cell dendrites (Frotscher et al., 2000). Asymmetric synapses are surrounded by 
astrocytes (Theodosis et al., 2008), amongst others responsible for glutamate clearance 
after release. Group II mGluRs are located peri-synaptically nearer the axonal part of 
the neuron facing away the synaptic cleft (Lujan et al., 1997) on MPP terminals and 
show a high glutamate affinity (Pin and Duvoisin, 1995). Immediately after presynaptic 
release glutamate can reach millimolar concentrations at least in the synaptic cleft 
(Barbour, 2001), but diffusion restricts the spatial range of released glutamate 
enormously (Min et al., 1998), and also astrocyte glutamate transporters can eliminate 
glutamate within milliseconds after release (Diamond, 2005). As we have shown in our 
experiments, astroglial glutamate uptake is one of the limiting factors tightly controlling 
the degree of mGluR activation. The high receptor affinity for glutamate implies 
activation even at very low concentration. However, the literature (Scanziani et al., 
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1997) and our systematic analysis of group II mGluR activation confirm that they do not 
activate during normal level of glutamate release during low-frequent activity.  
Obviously the interplay between the anatomical arrangement of involved neurons and 
glia, the sub-cellular location of presynaptic group II mGluRs and the competitions 
brought to the synapse by glutamate transporters makes receptor activation highly 
specific to certain presynaptic inputs which cause a spread of neurotransmitter that 
overcomes the strong homeostasis between release and removal. This suggests a group 
II mGluR activation by at least a homo-synaptic mechanism, meaning that glutamate 
spills over from the same synapses in the stimulated fibre tract to bind to the 
metabotropic receptors (Cosgrove et al., 2011). How strong this input must be, 
illustrates for example a study from Diamond and Jahr (2000). High frequent 
stimulation (3, 4, 9, 10stimuli at 100Hz) did not overwhelm astrocyte glutamate 
transporter, giving rise to the assumption that group II mGluR activation needs a much 
stronger presynaptic activity. In accordance with studies, for example from Kew (2001) 
and Scanziani (1997), our systematic analysis of group II mGluR supports this 
assumption.  
If we think about the naturally occurring firing pattern in this range, the possibilities are 
restricted. Medial perforant path fibres are projections mainly from layer II of the 
entorhinal cortex (Segal and Landis, 1974, Steward and Scoville, 1976, Ruth et al., 
1982, Tamamaki and Nojyo, 1993, Witter, 2007). Depending on the behavioural state of 
the rat, for example REM sleep phase (Jouvet, 1969) or voluntary, preparatory, 
orienting or exploratory activities (Vanderwolf, 1969), layer II and III entorhinal cortex 
neurons can fire in a theta (5-10Hz) (Buzsaki, 2002, Shao and Dudek, 2011) and/or 
gamma (40-100Hz) frequency pattern (Bragin et al., 1995). The latter is modulated by 
theta cycles. Layer II and III entorhinal cortex neurons convey these collective signals 
to their targets within the hippocampus, for example to the dentate gyrus. The neurons 
there are also entrained into theta-gamma activity in conjunction with their entorhinal 
input (Bragin et al., 1995, Chrobak et al., 2000).  
These finding suggest that the information flow from the entorhinal cortex to the 
hippocampus is regulated in a frequency dependent manner (Gloveli et al., 1997). 
Potentially, group II mGluRs could activate during those high frequent firing pattern 
and regulate the incoming information.  
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Apart from this, high frequent activity in the dentate gyrus occurs also, if this region 
undergoes multiple and consistent pathological changes (Dudek et al., 2002). It has been 
shown that the “gate“- function of the dentate gyrus is disturbed, which normally limits 
the incoming activity from the entorhinal cortex. In rats with kindling induced epilepsy, 
theta rhythms cause epileptiform discharges in the DG (Shao and Dudek, 2011) which 
give rise to the idea, that presynaptic group II mGluRs play also a modulatory role in 
this context. 
 Another possibility is that, group II mGluR could activate during high pathological 
levels of glutamate arising through disturbed glutamate uptake, maybe arising by a 
reduced or missing glial glutamate transporter expression (Tanaka et al., 1997, Rao et 
al., 1998) 
 
 
4.5 Potential significance of group II mGluR mediated 
inhibitory modulation of presynaptic glutamate release in 
the hippocampus 
Activation of mGluRs has different outcomes depending on the location of the receptor, 
the source of glutamate and the frequency of the input. We suggest that presynaptic 
inhibitory group II mGluRs at medial perforant path terminals activate cooperatively, 
presumably by a homo-synaptic mechanism, implemented by high frequent entorhinal 
activity entering the dentate gyrus which causes a high ambient glutamate concentration 
in the ECS. “Cooperatively” means convergence of released glutamate from many 
synapses might be necessary to activate group II mGluRs effectively. The opposite 
would be an autarkic activation via the glutamate released from the synapse where the 
mGlu receptors are located. It is known that in the DG, high frequent firing occurs 
during behaviour like sleep and exploration, strongly linked to memory formation and 
consolidation.  
We suggest, that group II mGluRs might act as fine-tuners of synaptic communication 
(Cosgrove et al., 2011) within learning and memory consolidation processes by acting 
persistently but weak over a hundreds to a thousands of millisecond time scale on the 
synaptic strength of a connection. Besides, the highly frequency dependent activation of 
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mGluRs gives rise to the assumption that these receptors might have evolved to keep 
glutamate transmission within the physiological range to prevent hyper-excitability or, 
for example, epileptic discharges from interfering with normal brain functions 
(Schoepp, 2001). 
4.5.1 mGluR mediated inhibition of glutamate release versus GABAergic 
inhibition 
Apart from inhibition on synaptic transmission via mGluRs, GABAergic inhibition is 
also evident in the hippocampus. GABAergic inhibition is mediated via ionotropic 
GABAA or metabotropic GABAB receptors which can both be presynaptically or 
postsynaptically, as well as extra-synaptically located. Fast GABAA receptor activation 
controls action potential firing in a point-to-point manner and inhibits dendritic Ca2+ 
spikes. Slower inhibitory responses (“tonic inhibition”), lasting 500 to 2000ms, are 
caused by GABAB or extra-synaptic GABAA receptor activation. Extra-synaptic 
GABAA and GABAB receptors are substantially activated by GABA spillover arising 
during repetitive stimulation or oscillatory activity of the neuronal network, 
respectively.  
GABAB receptors show similarities to metabotropic glutamate receptors (Kaupmann et 
al., 1997). They are also coupled with Gi/o proteins, either to inhibit neurotransmission 
presynaptically (Thompson et al., 1993, Wu and Saggau, 1997) or to decrease 
postsynaptic excitability by opening G-protein coupled inwardly rectifying K+ (GIRK) 
channels (Sodickson and Bean, 1996, Luscher et al., 1997). The GABABR mediated Gi/o 
protein activation can also depress adenylyl cyclase and reduce Ca2+ channel currents 
(Mintz and Bean, 1993, Kerr and Ong, 1995). In addition, our study provided evidence 
that presynaptic inhibitory group II mGluRs show very similar activation kinetics 
compared to GABAB receptors (Dittman and Regehr, 1997). One can get the 
impression, that mGluRs and GABAB receptors fulfil the same function. However, there 
are differences between inhibition at excitatory synapses mediated by mGluRs and 
GABAB receptors. Whereas the activation of presynaptic mGluRs is coupled to the 
synaptic release of glutamate during high frequent activity, causing feedback inhibition, 
activation of GABAB receptors is in contrast dependent on transients of  ambient GABA 
and potentially serve to detect enhanced and/or simultaneous activity  of GABAergic 
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interneurons, for example when many interneurons fire synchronously in population 
oscillations (Bragin et al., 1995, Ylinen et al., 1995).  
It is interesting that these two mechanism of inhibition on synaptic transmission can act 
together, which is described as hetero-synaptic crosstalk (Fernandes et al., 2011). 
mGluRs can control GABA release and/or GABA receptor activity (Chen and Bonham, 
2005, Lu, 2007, Errington et al., 2011) and GABA receptors can in turn control 
glutamate release and/or mGlu receptor activity (Hirono et al., 2001, Ladera et al., 
2008). The integrated combination of these influences determines their functional 
contributions to information processing. 
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5 Summary 
Whereas pharmacological evidence suggests that presynaptic group II mGluRs function 
as autoreceptors and predominantly mediate a strong negative feedback regulation on 
synaptic transmission (Ugolini and Bordi, 1995, Macek et al., 1996, Dietrich et al., 
1997, Kilbride et al., 1998), the little knowledge about endogenous activation created 
reasonable doubts on this theory, because the synaptic activation caused a much weaker 
inhibitory effect on transmitter release compared to the agonist induced depression 
(Scanziani et al., 1997, Kew et al., 2001). However, nobody had tried yet to shed light 
on this discrepancy finding out whether there is some truth in it or not. If so, it could 
drastically change the view about potential functional roles (Conn and Pin, 1997, 
Schoepp, 2001, Pinheiro and Mulle, 2008, Byrnes et al., 2009, Niswender and Conn, 
2010) presynaptic inhibitory group II mGluRs might play in neuronal processes or 
disorders. In my thesis, I attended to this matter and performed a systematic analysis of 
group II mGluR activation by synaptically released glutamate in order to find the 
presynaptic factors controlling mGluR activation, the maximum mGluR induced 
inhibition and to define the time course of action on synaptic transmission. Apart from 
presynaptic firing pattern, mGluR activation is also controlled by glutamate uptake 
mechanism (Huang and Bergles, 2004), diffusion (Asztely et al., 1997, Kullmann and 
Asztely, 1998, Min et al., 1998), sub-cellular location (Lujan et al., 1997, Muly et al., 
2007), receptor affinity (Conn and Pin, 1997) and receptors kinetics (Parnas and Parnas, 
2007). The interplay of all these factors account for the presynaptic mGluR effect on 
glutamate release. In general, at excitatory synapses, fast chemical synaptic 
transmission occurs in a point to point fashion. Glutamate binds to ionotropic glutamate 
receptors in the active zone of presynapses and gets simultaneously cleared from the 
synaptic cleft via diffusion and astrocyte transporter mediated uptake within 
milliseconds (Scanziani et al., 1997). Extra-synaptically located receptors at 
presynapses like group II mGluRs can only activate, if released glutamate overcomes 
the homeostasis between release and removal and gets the chance to diffuse to the 
receptor. First, I performed fEPSP recordings and tested mGluR activation with a 
stimulation protocol that has already been tested successfully (Kew et al., 2001), 
checked the influence of slowed glutamate reuptake on mGluR activation and could 
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show that the mGluR mediated inhibition on synaptic transmission is strongly 
dependent on glial glutamate uptake. Raising the number of stimuli within the activating 
burst led to an increase in inhibition until a plateau was reached, mainly due to 
presynaptic fatigue during sustained stimulation. Changing the inter pulse interval 
within a burst of constant duration revealed that mGluRs also integrate the firing 
frequency of the presynaptic neurons. Surprisingly, repetitive burst application did not 
cause a temporal summation of mGluR activity. When the time course of mGluR action 
on synaptic communication was determined, a faster activation and a slower 
deactivation component could be identified. However, none of the stimulation protocols 
used turned out to cause an mGluR effect as drastic as a pharmacological effect, raising 
the question whether the functional significance of the receptor might rather be the 
duration of inhibition and not the strength. I focused on the kinetics in detail and 
determined the activation- and deactivation kinetics of the mGluR mediated inhibitory 
process by a combined Ca2+ imaging and glutamate uncaging method. For the activation 
kinetics the time constant could be clearly identified (τ = 150 ms), whereas in contrast, 
an upper and a lower estimation had to be made for the deactivation kinetics (τ ~ 150 – 
1870 ms), arising from limitations of the used technique. Apart from that, these data 
strongly supported the assumption that presynaptic inhibitory group II mGluRs act as 
modulators, generating a sustained effect on synaptic communication within the MML 
of the DG whose integral inhibition might be comparable to a receptor which mediated 
a direct and strong effect. Concerning the functionality, it seems to be likely that group 
II mGluRs are fine-tuner of entorhinal cortex activity entering the DG, or, in the case of 
pathological changes, they might act protective to keep glutamate transmission with the 
physiological range to prevent hyper-excitability from interfering with normal brain 
functions.  
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6 Zusammenfassung 
Das Resultat pharmakologischer Aktivierung präsynaptischer Gruppe II mGluRs lässt 
vermuten, dass jene Rezeptoren als Autorezeptoren fungieren und vorwiegend eine 
negative Rückkopplungsregulation synaptischer Signalübertragung bewirken (Ugolini 
and Bordi, 1995, Macek et al., 1996, Dietrich et al., 1997, Kilbride et al., 1998). Im 
Gegenzug dazu ist wenig bekannt über die physiologische Aktivierung Gruppe II 
mGluRs über den endogenen Liganden Glutamat. Das wenige Wissen darüber lässt 
jedoch große Zweifel an der Rolle präsynaptischer Gruppe II mGluRs als 
Autorezeptoren entstehen, da die synaptische Aktivierung dieser Rezeptoren über die 
Ausschüttung von Glutamat zu einer sehr viel geringeren Hemmung der 
Signalübertragung an Synapsen führt (Scanziani et al., 1997, Kew et al., 2001). Trotz 
dieser enormen Diskrepanz hatte bisher niemand versucht darüber Aufschluss zu geben. 
Würde sich die Annahme eines signifikanten Unterschiedes zwischen 
pharmakologischer und endogener Glutamat vermittelter Aktivierung präsynaptischer 
Gruppe II mGluRs verfestigen, müssten die potentiellen funktionelle Eigenschaften die 
diesen Rezeptoren angedacht sind, nochmals gründlich überdacht werden. In meiner 
Doktorarbeit nahm ich mich dieser Sache an und führte eine systematische Analyse über 
die synaptische Aktivierung Gruppe II mGluRs durch um herauszufinden, welche 
präsynaptischen Faktoren die Rezeptoraktivierung kontrollieren, wann die mGluR 
vermittelte Hemmung nach synaptischer Aktivierung maximal ist und wie die 
Aktivierung- und Deaktivierungskinetik der mGluR vermittelten Hemmung aussieht. 
Neben der Aktivität präsynaptischer Neurone spielen auch Faktoren wie 
Glutamataufnahme (Huang and Bergles, 2004), Diffusion (Asztely et al., 1997, 
Kullmann and Asztely, 1998, Min et al., 1998), subzelluläre Lokalisation (Lujan et al., 
1997, Muly et al., 2007), Rezeptoraffinität (Conn and Pin, 1997) und Rezeptorkinetik 
(Parnas and Parnas, 2007) eine wesentliche Rolle bei der Aktivierung präsynaptischer 
Gruppe II mGluRs. Das Zusammenspiel all dieser Faktoren bestimmt im Wesentlichen 
die mGluR-Wirkung auf die neuronale Signalübertragung. Im Allgemeinen verläuft die 
Signalübertragung an exzitatorischen Synapsen von „Punkt zu Punkt”. Ausgeschüttetes 
Glutamate bindet an hochaffine ionotrope Glutamatrezeptoren im synaptischen Spalt 
und wird simultan über Diffusion und astrozytäre Glutamataufnahme schnell aus dem 
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Extrazellulärraum entfernt (Scanziani et al., 1997). An Präsynapsen extrasynaptisch 
lokalisierte Rezeptoren, z.B. Gruppe II mGluRs, können nur aktivieren, wenn 
synaptisch ausgeschüttetes Glutamat die Homöostase zwischen Ausschüttung und 
Entfernung überwindet und die Chance erhält zu dem von synaptischen Spalt entfernter 
liegenden Rezeptor zu diffundieren.  Zuallererst führten wir Feldpotentialmessungen 
durch und testeten Gruppe II mGluR Aktivierung mit einem bereits erfolgreich 
erprobten Stimulationsprotokoll (Kew et al., 2001). Eine Verlangsamung der Glutamat-
Aufnahme durch eine partielle Blockade astrozytärer Glutamattransporter bewirkte eine 
Vergrößerung des mGluR vermittelten hemmenden Effekts auf die synaptische 
Signalübertragung. Dies verdeutlichte eine starke Abhängigkeit der mGluR Aktivierung 
von der Glutamataufnahme. Eine Erhöhung der Anzahl an Stimuli innerhalb der 
konditionierenden Bursts führte zu einer Steigerung der mGluR Aktivierung bis ein 
Plateau erreicht wurde, hauptsächlich hervorgerufen durch eine Erschöpfung der 
Präsynapsen während anhaltender Stimulation. Wurde das Inter-Stimulus-Intervall 
innerhalb einer konditionierenden Salve relative konstanter Dauer verändert, konnte 
zudem eine Abhängigkeit der mGluR Aktivierung von der Stimulationsfrequenz gezeigt 
werden. Die Gabe sich wiederholender Salven führte wider Erwarten zu keiner 
Steigerung der mGluR Aktivierung. Die Untersuchung des Zeitverlaufs des 
präsynaptischen Gruppe II mGluR vermittelten hemmenden Effekts auf die synaptische 
Signalübertragung verdeutlichte eine schnellere Aktivierungs- und eine langsamere 
Deaktivierungskinetik. Alles in allem zeigte die systematische Analyse synaptischer 
Gruppe II mGluR Aktivierung, dass der maximal erreichbare hemmende Effekt weit 
unter dem liegt, der über pharmakologische Gruppe II mGluR Aktivierung erreicht 
werden kann. Dies lässt Zweifel über die Funktionalität der mGluRs aufkommen. 
Möglicherweise fungieren sie nicht als Autorezeptoren, eine Starke und direkte 
Hemmung vermittelnd, sondern wahrscheinlicher als Rezeptoren die einen 
schwächeren, aber dauerhaften Einfluss auf synaptische Kommunikation ausüben. 
Aufgrund dieser Annahme untersuchten wir die mGluR-Kinetik mittels eines 
kombinatorischen Ca2+ imaging und Glutamat uncaging Ansatzes im Detail. 
Wohingegen die Zeitkonstante der Aktivierungskinetik bestimmt werden konnte (τ = 
150ms), stellte sich die Bestimmung der Deaktivierungszeitkonstante als schwierig 
heraus.  Eingeschränkt durch methodische Limitierungen musste für die Deaktivierung 
eine untere und obere Abschätzung gemacht werden (τ ~ 150 – 1870ms). Dennoch, trotz 
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dieser Einschränkungen, unterstützen diese Resultate unsere Annahme betreffend der 
Gruppe II mGluR Funktionalität die andeutet, dass jene Rezeptoren eher als 
Modulatoren agieren und einen schwächeren, aber lang anhaltenden hemmenden Effekt 
auf die synaptische Signalübertragung ausüben. Der Effekt muss nicht weniger wichtig 
sein im Vergleich zu einem Rezeptor, der z.B. eine starke und direkte Hemmung 
vermittelt, denn die integrale Hemmung könnte zwischen beiden 
Rezeptorwirkungsarten vergleichbar sein. Innerhalb des Gyrus dentatus könnten 
präsynaptische Gruppe II mGluRs als Fein-Modulierer eingehender entorhinaler 
Kortexaktivität dienen, oder, im Falle pathologischer Veränderungen, eine 
Schutzfunktion einnehmen indem sie die glutamaterge Signalübertragung in einem 
physiologischen Bereich halten, verhindernd, dass über-erregbare Neurone normale 
Hirnfunktionen stören.   
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7 Perspectives 
In this study, we provided new insights about presynaptic inhibitory group II mGluR 
activation. Within the scope of our experiments, we were able to identify presynaptic 
and extrinsic factors controlling mGluR activation and to shed light on mGluR mediated 
inhibitory kinetics. However, many questions remain and the work on presynaptic group 
II mGluRs should be continued to answer open issues. Some important aspects I would 
like to mention here. For example, it would be important, especially to remove doubts, 
to find a technique to determine the deactivation kinetics as exactly as possible because 
we were only able to provide approximations. One suggestion would be to remove 
glutamate enzymatically after uncaging to minimize the probability of having persistent 
glutamate within the extracellular space which might keep glutamate receptors activated 
after uncaging. Moreover, other interesting aspects which should be brought in focus are 
how a change in transmitter release probability could affect mGluR activation.  Also, 
studies to provide more evidence concerning the question of whether presynaptic group 
II mGluRs are activated self-sufficiently or cooperatively would be profitable.  If the 
latter seems to be more likely, it should be clarified whether the activation is a homo- or 
hetero-synaptic mechanism. These are only a few ideas, but I think it is enough to 
highlight that the puzzle is still incomplete and more research on presynaptic mGluRs 
can and should be done to sharpen our understanding about mGlu receptor functionality 
and its context in brain function.  
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